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Tobacco smoking is a worldwide epidemic that is responsible for diseases and death rates 
that surpass those attributed to a combination of other causes (e.g. cancer, HIV, accidents). A 
major mediator of tobacco-smoke related negative consequences is nicotine. Nicotine is an 
addictive poison that entraps users in a vicious cycle of constant drug seeking and reinforcement. 
Despite the public health policies and laws enforced to decrease the habitual smoking, it is still 
prevalent, especially among adolescents. According to WHO, 40% of children and up to 60% of 
teenagers are passively and actively exposed to tobacco smoke. Early life stages are more 
vulnerable and sensitive to environmental and life experienced stresses. At that stage, stresses 
can have enduring effects that not only persist until adulthood, but are also inherited to the 
subsequent generations. With respect to nicotine, a wealth of studies have investigated the dose 
and time-dependent effects of this chemical on multiple systems including cell lines and model 
organisms. However, the transgenerational effect of nicotine exposed during post-embryonic 
stages has not been reported. On the molecular level, an increasing number of popular findings 
that show the involvements of certain microRNAs in physiological processes have expanded to 
include response to nicotine. Nevertheless, a systematic profiling of microRNA expression levels 
is yet to be determined.  In our study, we employed C. elegans as our model to investigate the 
transgenerational effect of nicotine exposure limited to the post-embryonic larval stages of the 
parent F0 generation. Two concentrations (20µM and 20mM) were chosen based on previous 
studies. We investigated the effect of nicotine on the behavior of L4 C. elegans (N2) across three 
generations (F0, F1, and F2). Here we report that nicotine altered the sinusoidal locomotion, 
body bends, and forward and backward speeds across three generations. Such represented an 
enduring and heritable addiction initiated by parental post-embryonic nicotine exposure. In 
addition our qRT-PCR results showed that direct nicotine exposure throughout the larval stages 
(30 hours), altered the systematic miRNA expression profiles in L4 C. elegans in a dose-
dependent manner. Through target prediction analyses coupled with background research, fos-1 
was predicted to be a key mediator of the addiction-like behavior in C. elegans larvae. 
Conclusively, our results offer novel insights on the sensitivity of early developmental stages to 
nicotine exposure. The behavioral transgenerational effect as well as the parental altered miRNA 
profiles will set the basis for future miRNA transgenerational analyses coupled with target and 
pathway validation. With this in mind, the need for suitable reference genes for normalization 
and reliable interpretations is necessary. We dedicated our last objective to identify reference 
gene candidates to serve this purpose. Based on results from five statistical approaches (geNorm, 
NormFinder, BestKeeper, dCt method, and RefFinder), we report that the expression levels of 
tba-1 and cdc-42 were the most stable among all of sixteen compiled genes. Taken together, our 
work is preliminary for a new research direction concerned with nicotine that would help support 
public health policies and awareness campaigns to further stress on the risks and dangers of 
tobacco addiction.  
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Chapter 1: Overview on Nicotine, C. elegans, and MicroRNAs 
Nicotine 
Tobacco Smoking: a global habit 
Efforts to set policies (e.g. TFI: tobacco free initiative) to optimize human health 
conditions have been continuously adopted to reduce and prevent diseases and health 
deterioration. According to WHO, tobacco-smoking is responsible for the death of nearly 6 
million individuals per year. This group represents half of the tobacco-exposed individuals, 
600,000 of which are second-hand smokers. As reported by CDC, the weight of the dangers of 
tobacco-smoking can be underscored by the death percentage that overrides deaths caused by 
HIV, alcohol, illegal drugs, murders, suicide, and vehicle-related injuries, combined (CDC 
2000–2004). Of the facts listed by WHO, the circle of second-hand smoking includes about 40% 
of children at home, a situation that doubles the likelihood of them growing up to be smokers. 
Unfortunately, tobacco smoking negatively affects every organ. The consequential health 
deterioration (e.g. cardiovascular, respiratory and reproductive diseases, cancer) and premature 
death constitutes a major economic burden as productivity decreases (USDHHS 2004). Among 
the 4000 chemicals that constitute tobacco, we will focus on nicotine as it is of the major 
contributors to tobacco’s effects.  
Nicotine chemistry and mechanism of action 
The pharmacological activity of nicotine from tobacco is not limited to its S-potent form. 
It peaks at the end of a cigarette smoking and is distributed in the human body within 20 minutes 
to reach tissues and organs (e.g. lungs, brain (with high efficiency), liver, kidney, spleen, skeletal 
muscle, placenta, amniotic fluid). With blood PH of about 7.4, nicotine is both ionized, non-
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ionized (membrane permeable), and bound to plasma proteins (Benowitz 1988; Matta, et al. 
2007). In humans, nicotine is primarily metabolized by the liver CYP2A6. As a result, its half-
life varies from two to eight hours depending on the smoking regularity with elimination time 
increasing even more (20 hours) in chronic heavy smokers.  
Nicotine is known to be psychoactive. Consequently, its target cells include, but are not 
restricted to, the mesolimbic reward pathways (Wada, et al. 1989). Nicotine-induced effects are 
complex as they appear to be dose-dependent, but not monotonic. A biphasic response has been 
reported where lower doses caused stimulation, while higher doses were associated with a 
depressant-like effect on the nervous system (Benowitz 1988) (Table 1.1; Figure 1.1). Nicotine 
generally binds to nicotinic AchR (ligand gated ion channels). The general model includes 
sensitization of the latter receptors after acute nicotine treatment, followed by desensitization 
after prolonged exposure. Depending on the cell type, the response to chronic nicotine treatment 
involves a decrease or increase in the concentration of these receptors resulting from the 
transcriptional or post-transcriptional modifications (Changeux 1991; Peng, et al. 1994; 
Waggoner, et al. 2000). The acetylcholine receptors will shift from resting, to short-term 
desensitized, to long-term inactivated states. The rate of becoming sensitized again depends on 
the receptor and the nicotine concentration. Generally, as the nicotine concentration decreases 
(after abstinence), the more receptors will become sensitized again. The more the receptors are 
altered on the surface of a variety of cells, which include but are not restricted to the brain 
reward system, the more the nicotine is needed for satisfaction from the pathological status (Dani 
and Heinemann 1996) (Figure 1.2). Such background information was used to form a basis for 
our hypothetical model to explain the phenotype observed in L4 N2 worms as a result of nicotine 
treatment as will be seen in the results section.  
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Nicotine addiction is a complex trait that is mediated by several factors (e.g. 
environment, genetics) (CDC 2010). Addiction is considered a maladaptive form of 
neuroplasticity (Sartor, et al. 2012). The fastest route to attain high nicotine blood peaks is 
through inhalation (e.g. cigarette smoke) (Benowitz 1988). Then, within 8-10 seconds, high 
nicotine arterial levels reach the brain (Matta, et al. 2007). This relatively easy route of 
administration only inflates the proportion of individuals affected. Several criteria act as a 
prerequisite for addictive behavior, but we focused on two extrapolatable features that are mostly 
relevant to -and were observed in- the behavior of our model organism. One state is known as 
“tolerance” and can be described as desensitization and adaptation to the stressor (i.e. nicotine), 
in which the initial repetitive dose produces a lesser effect (e.g. ligand concentration at the 
receptor site). A more reliable index of addiction is the “withdrawal” (CDC 2010; Shiffman 
1989), whose symptoms are similar to those resulting from the chemical-induced chronic 
toxicity, possibly persisting even after its removal. Therefore, “withdrawal”-related phenotypes 
should be interpreted with caution to avoid analytical confounds (Mitchell, et al. 2010). 
Meanwhile, other addiction-related behaviors are usually tested in higher organism such as the 
ability of the chemical (e.g. nicotine) to cause positive (pleasurable effects) or negative 
(reduction of withdrawal symptoms) reinforcement. Such remains relatively ambiguous in the 
case of nicotine (Benowitz 1988; CDC 2010) and are less likely to be easily modeled by C. 
elegans. 
Caenorhabditis elegans: a biological model 
It was only 60 years from C. elegans’s isolation that its appreciation as a biological 
model was established (Brenner 1974; Maupus 1990). The latter is attributed to its ease of 
maintenance with E.coli (OP50) as food source on temperatures ranging between 15 and 25
o
C in 
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liquid or on solid media (Brenner 1974; Wilson , et al. 2010). Its short generation time of 2-3 
days at 20
o
C  and lifecycle of 2-3 weeks (Figure 1.3) makes it relatively convenient for lifespan 
as well as trans-generational studies. To reach adulthood, the embryo has to pass through four 
larval stages, the second (L2) of which can be interrupted by stressful conditions (e.g. starvation, 
overcrowding) (Altun and Hall 2009). The worm enters a resistant dauer stage which can live to 
several months and returns to L4 following favorable conditions. “Deceptively simple, but 
simply deceptive” -a term used by Gruber et al. (Gruber, et al. 2009)- is a suitable description of 
a simple multicellular transparent organism that allows ethical investigations from cellular (e.g. 
apoptosis) (Kirienko, et al. 2010; Kokel, et al. 2006) to  holistic organism level phenomena (e.g. 
ageing) (Greer, et al. 2011; Hamilton, et al. 2005). Interestingly, normally arising from a 0.1-
0.2% mutation rate (Ward and Carrel 1979), the males -distinguished by their fan shaped tail 
(Emmons 2005)- can be further induced and are useful for genetic cross-linking experiments 
(McGraw-Hill-Higher-Education 2011). The number of offsprings produced by a self -fertile 
hermaphrodite increases from 300 to 1000 in case of mating (Riddle, et al. 1997). 
C. elegans is ideal for biotechnological manipulations (fluorescence-tags) which can be 
visualized by a simple microscope, high-throughput drug design (Geary and Thompson 2001; 
Giacomotto and Segalat 2010; Kaletta and Hengartner 2006; Markaki and Tavernarakis 2010) as 
well as research in cancer (Kirienko, et al. 2010) and other diseases like Alzheimer’s, and 
Huntington (Ewald and Li 2009; Kaletta and Hengartner 2006; Siddiqui, et al. 2008; Voisine, et 
al. 2007). In order to understand certain phenotypes, critical pathways and mechanisms (Hulme 
and Whitesides 2011; Schulz, et al. 2007), researchers took advantage of the worm’s anatomy, its 
differentiated tissue (e.g. neurons, muscles) as well as its fully sequenced 100 MB genome. The 
latter shares 80% homology with the human genome (e.g. CEP-1/p53, let-60/RAS (Beitel, et al. 
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1990) (Lai, et al. 2000; Pinkston, et al. 2006; Sonnhammer and Durbin 1997), but at the same 
time has less redundancies in coding and noncoding genes (Consortium 1998; Kazazian 2004). 
This allowed extrapolations to be done with relative ease as will be further discussed in the 
following paragraphs. 
As for the toxicological and biomedical fields, C. elegans has a lot to offer. It has been 
used to test and study the mechanism of action of many chemicals, heavy metals and drugs 
(Kaletta and Hengartner 2006; Leung, et al. 2008; Markaki and Tavernarakis 2010; Mitchell, et 
al. 2010; Wang and Xing 2008). Its contributions extended to include neuroscience. Among the 
959 cells, the C. elegans adult hermaphrodite has 302 (one third) of which are neurons, 20 of 
which are pharyngeal, 32 (10%) of which are involved in chemosensation, and the rest being 
somatic (Hart and Chao 2010). The command interneurons (AVA, AVB, AVD, AVE, and PVC) 
act as mediators. They perceive the signal from the chemosensory neurons, transmit it to the 
motor neurons, and therefore allow the control body muscle contraction (Von Stetina, et al. 
2006). As shown by Leung et al. (Leung, et al. 2008), neurostudies on C. elegans offer an in 
depth analysis down to a single-neuron resolution. This is based on delineated systems, including 
but not restricted to the nervous system (Brenner 1974; Sulston 1983; Sulston, et al. 1983; White, 
et al. 1986) coupled with technologies allowing single cell laser ablation (Feng, et al. 2006) and 
is promoted by the relative ease of establishing mutant strains (Antoshechkin and Sternberg 
2007).  The worm’s simple nervous system includes features conserved and common to higher 
organisms neurotransmitters (acetylcholine, serotonin, dopamine, glutamate, gamma-
aminobutyric acid, octopamine, tyramine) (Leung, et al. 2008; Loer 2010) as well as other 
proteins that play a major role in neuro-signaling (e.g. 29 AchR subunits) (Jones, et al. 2007). 
Consequentially, an observable phenotype is reflective of the net inner interactions and 
 6 
 
processes, a relationship that is often used by researchers when attempting to understand the 
mechanism of action of treated chemicals or particular environmental conditions. 
In our study, we took advantage of the behavior of the worms. C. elegans’s locomotion is 
a result of rhythmic undulatory movements. The simple anatomy coupled with its well defined 
nervous system allows the study of neural circuits in response to different conditions. Briefly, the 
worms’ locomotion is dependent on the motor circuitry that triggers sinusoidal waves. The latter 
drives alternating muscle excitation/relaxation along the dorso-ventral axes. Consequently, the 
worms move forward or backward as a result of posteriorly or anteriorly-directed-wave-
propagation, respectively. The AVA and AVD command interneurons drive backward 
movement (reversals), while the PVC and AVB neurons drive the forward movement.  An 
example of the complexity provided by this system is the movement decision. The latter is not 
restricted to the interaction of these distinct inter-neural circuits, but also is due to the 
involvement of each circuit in the regulation of the opposing movement (Chalfie, et al. 1985; 
Von Stetina, et al. 2006; Zheng, et al. 1999). All of the above details provide a rationale for 
selecting C. elegans as our ideal simple organism to study complex nicotine-associated behavior 
and molecular alterations. 
Nicotine and C. elegans 
In C. elegans, nicotine alters some behavior such as egg laying, pharyngeal pumping, 
muscle contraction, and male spicule ejection (Matta, et al. 2007). In addition, the emergence of 
C. elegans as a model for nicotine addiction was also reported (Feng, et al. 2006). In fact, 
depending on the experimental design for nicotine treatment, C. elegans exhibited acute 
response, tolerance, withdrawal, and sensitization (Feng, et al. 2006). Unlike other models (e.g. 
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rats), the half-life of nicotine in C. elegans is not known. Therefore, nicotine is constantly, rather 
than intermittently, supplied during the experimental period. In addition, the presence of a cuticle 
acts as a barrier to many chemicals. Based on the previous reports, it is assumed that the internal 
concentration of any chemical is much less than the supplied dose (Matta, et al. 2007). 
Accordingly, all of the mentioned points were taken into account when designing our 
experimental methods and material for optimal investigations on the behavioral level, 
complimented by molecular assays mainly focusing on, but not restricted to, our main area of 
interest: miRNAs.  
MicroRNAs 
Introduction to epigenetics and miRNA 
The genome encodes all physiological functions, but its expression is tightly regulated in 
response to a network of factors. Extensive research has been devoted to dissect the factors 
involved in gene regulation and has provided clues concerned with the environmental 
contribution in shaping physiological phenotypes. Interestingly, such environmentally-induced 
changes are mainly mediated by diverse epigenetic processes which in most cases result in 
heritable changes that do not involve changes in the DNA (Bird 2007; Goldberg, et al. 2007). 
Recently, epigenetics has been considered to be the link between the environment and the 
genome that contribute to emergent cellular processes. As mentioned before, we are mainly 
interested in one of the epigenetic regulators known as miRNAs (Zhang and Ho 2011). 
In the last decade, the discovery of a master gene regulator emerged. It was in 1993 in C. 
elegans that lin-4 was involved in regulation via an RNA-RNA antisense interaction (Lee, et al. 
1993). Afterwards, miRNAs were ubiquitously discovered in all eukaryotic organisms (He and 
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Hannon 2004). Over 200 and 1000 miRNAs have been discovered in C. elegans and Humans, 
respectively. Initially reported to control the developmental timing in C. elegans (Ambros 1989), 
their roles extended to diverse  physiological and pathophysiological processes (Ambros 2003; 
Aukerman and Sakai 2003; Chen, et al. 2004; Kim 2005; McManus 2003).  
Definition and occurrence 
MicroRNAs are conserved non-coding regulatory RNAs found in Eukaryotes (Carthew 
and Sontheimer 2009). They are expressed in a tissue and temporal specific manner. When 
expressed, they exist in relatively high copy number (Bartel 2004). They are transcribed either 
from intergenic (more common in plants) or intragenic regions (Shabalina and Koonin 2008). 
The regulation of miRNA transcription has not yet been clearly described (Sato, et al. 2011). 
When found intragenically, they are usually transcribed from the promoter of the gene they 
reside within (Sato, et al. 2011). Other miRNAs can be found within introns and possibly 
regulated by their own independent promoter (Toyota, et al. 2008). miRNAs can be found within 
clusters (mostly in animals) (Shabalina and Koonin 2008) leading to the production of a 
polycistronic transcript (Bartel 2004). However, individual miRNAs within clusters have been 
documented to be regulated individually as well (Saito, et al. 2006). On the other hand, the 
biogenesis of the miRNAs has been moderately studied and will be discussed in the following 
paragraph.  
MicroRNA biogenesis 
Two biogenesis pathways have been reported. A less common pathway depends on pri-
miRNA splicing (O'Carroll and Schaefer 2013; Okamura, et al. 2007) which will give rise to 
mirtrons. On the other hand, the main biogenesis pathway involves transcription mainly via RNA 
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polymerase II (III) (Bartel 2004). The transcribed pri-miRNA is capped, possibly polyadenylated 
(Kim 2005; Ohler, et al. 2004) and has one or more stems, each of about 33 imperfectly paired 
bases. The stem is bordered by a loop to form a stem-loop structure that is flanked by single 
stranded regions (Bartel 2004). In the nucleus, the processing is stepwise and initially involves 
the cleavage of the flanking regions of pri-miRNA by an RNase III called Drosha (Kim 2005) to 
give rise to double stranded pre-miRNAs. Then, the pre-miRNA will be exported out of the 
nucleus to the cytoplasm by exportin 5 and Ran-GTP (Bartel 2004) and will be processed by 
another RNase III known as Dicer (Kim 2005). In plants, Dicer (Dcl-1) mediates both the first 
and second processing steps in the nucleus after which the miRNA duplex is transported to the 
cytoplasm (Bartel 2004; Kim 2005). Therefore, Dicer substitutes for both Dicer and Drosha in 
plants. Cooperatively, Dicer with other regulatory proteins will then cleave pre-miRNA to a 
miRNA: miRNA* duplex with imperfect complementarity (Carthew and Sontheimer 2009). The 
duplex will be loaded onto a trimeric complex: Dicer, Ago and TRBP (Hornbeck, et al. 2012). 
Afterwards, the guide strand will be incorporated to RISC complex while the other passenger 
strand is discarded. The selection of the guide strand is not restricted to the one with the less 
stable 5’ end (Okamura, et al. 2008; Tomari and Zamore 2005). As its name implies, the guide 
strand directs the silencing complex to the target sequence. Recognition of the target sequence is 
generally at the 3’ UTR, and is based on a seed sequence (nucleotides: 2-8 in the miRNA) 
(Carthew and Sontheimer 2009). Reasonably, downstream of the biogenesis pathway, the 
miRNAs’ state and interactions mediate gene regulation (Figure 1.5). 
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MicroRNA’s role in gene regulation 
Two major pathways have been hypothesized to describe miRNAs modes of actions. The 
first is by mRNA cleavage and is more common in plants as a result of the relatively higher 
degrees of complementarity between miRNA-mRNA target ORF (Bartel 2004; Shabalina and 
Koonin 2008). In animals, it appears that the default silencing mechanism is translational 
repression (Shabalina and Koonin 2008). Silencing depends primarily on RISC (i.e. RNA-
Induced Silencing Complex) which is formed from Argonaute proteins complexed with several 
factors, mainly GW182 proteins (Jakymiw, et al. 2005; Liu, et al. 2005).  
The Argonaute proteins are a universal and conserved family of proteins with major 
active roles in the miRNA-mediated gene silencing. They have a bilobal structure with an N-
terminal and PAZ (Piwi-Argonaute-Zwilli) domains on one side, and MID (Middle) and PIWI 
domains on the other end. Some species (e.g. humans) might have more than one type of 
argonautes, a few of which are characterized by endonucleolytic activity. Also known as slicer, 
those argonaute proteins interact through their MID domain with the sugar-phosphate backbone 
of the associated miRNA. Thus, the bases are free to bind to the target mRNAs (Ender and 
Meister 2010).  
Another crucial component of the silencing machinery are the GW182 proteins (i.e. AIN-
1 and AIN-2 in C. elegans). GW182 binds to AGO through more than one domain (i.e. NED, 
and silencing domain). In addition, GW182 interacts with the PABC domains found on PABP 
and EDD (E3 ubiquitin ligase identified by differential display) and acts as a docking site for 
deadenylase complexes. PABP interacts with a group of players such as PAIP1, PAIP2, and 
eRF3 to promote translational activation, repression and termination, respectively. Together with 
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TOP (Transducer of ERBB2) or PAN (poly-A nuclease), PABP also affects mRNA 
deadenylation and decay. EDD on the other hand associates with other silencing effectors. Thus, 
GW182 provide a platform for the association of a myriad of proteins with context-dependent 
functions mainly in target translational regulation (Fabian and Sonenberg 2012).  Possibilities of 
the latter to occur at or post translational initiation have been reported (Ding and Grosshans 
2009; Petersen, et al. 2006).   
Conceptually, the interplay between translational repression and mRNA destabilization 
has been discussed (Fabian and Sonenberg 2012), but dissecting the exact pathway is not trivial. 
Three major models have been reported to explain the phenomenon. The first was described by a 
possible competition between RISC members with eIF4E to prevent the recruitment of the 
translational machinery (Mathonnet, et al. 2007). A second model was described as the RISC-
dependent recruitment of eIF6, which usually associates with the 60S ribosomal subunit to 
prevent its premature binding to the translational machinery. Such would disrupt the sequential 
events occurring at translation initiation (Chendrimada, et al. 2007; Fabian and Sonenberg 2012). 
Another way could occur through the deadenylation or decapping of the mRNA which prevents 
circularization and induces the destabilization of the mRNA (Behm-Ansmant, et al. 2006; Fabian 
and Sonenberg 2012). All would lead to an increase in the susceptibility of exonuclease-
dependent degradation of the target mRNAs (Carthew and Sontheimer 2009). 
MicroRNA characteristics 
An important miRNA feature is evident in its diversity which more likely arises from 
mutations in the miRNA sequences within their host transcripts than from sequence duplication 
events. Then, the regulatory sequences (promoters, enhancers) of the host transcript can be 
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readily used (Lu, et al. 2008) and contribute to their emergence. To add to the enrichment of 
miRNA-dependent regulations, it has been reported that one miRNA can target many genes, and 
one gene can be regulated by many miRNAs (Ritchie, et al. 2009; Wu, et al. 2010). 
Despite their diversity, miRNAs are known for their precise ends (Carthew and 
Sontheimer 2009). Though the cleavage is mediated by RNase III family members (Drosha and 
Dicer), the precision of the cuts is promoted by the cofactors associated with these ribonucleases 
or dsRNA binding subunits. Dorsha depends on DGCR8. Together, they form the 
microprocessor as DGCR8 positions Drosha at the intersection of the single and double strands 
in the pri-miRNA and allows the cleavage 11 bp away from this point (minimal distance required 
for its action) (Han, et al. 2006). Dicer on the other hand will bind via its PAZ domain more 
likely to the 3’ overhang situating the RNase III domain 22 nucleotides away. This will 
consequently lead to the cleavage of a ~ 22 nt miRNA duplex (Kim 2005).  
Interestingly, RNAi covers only one side of possible miRNA actions. It seems that its 
regulatory role is context dependent. miRNAs can have activating roles under certain conditions. 
For example, let-7 becomes a translational activator in G1 arrested cells (Vasudevan, et al. 
2007). Another situation is evident in miR-10a which activates translation when interacting with 
5’ UTRs while it becomes a repressor once interacting with 3’ UTR (Orom, et al. 2008). 
Interestingly, 3’ UTR-binding proteins have the potential to antagonize as well as agonize 
miRNA-mediated silencing by altering the 3’ UTR secondary structure. Thus, accessibility of the 
small RNAs to their targets would be influenced. Such a mechanism has been described to 
explain miRNA-associated translational activation. In the latter case, a strong transcription 
repressor is bound in close proximity to the miRNA binding site. RISC competes with the 
 13 
 
repressor for mRNA access and leads to an apparent translational activation if the protein is a 
stronger repressor than RISC (Brodersen and Voinnet 2009).  
Hypothesis 
We hypothesize that nicotine exposure during the post-embryonic stage in C. elegans is 
associated with transgenerational behavioral effects. Also, we postulate that nicotine causes 
systematic alterations in the miRNA profiles in L4 C. elegans (N2).  
Research Objectives 
Our main theme is to explore the transgenerational effect of nicotine treated during the 
early developmental stages in C. elegans N2 hermaphrodites. In order to accomplish our aim, our 
tactic involved dividing our broad hypothesis into three main objectives presented below. Based 
on previous publications (Sobkowiak, et al. 2011), two nicotine concentrations of a thousand fold 
difference (20µM and 20mM) were chosen to test for possible dose-dependent effects (Figure 
1.4).  
Objective One: To study the effect of nicotine on the behavior of C. elegans across three 
generations (Chapter 2).  
As detailed in the methods section, video-recordings were performed on worms 
belonging to three nicotine treatment groups (i.e. control, 20µM, and 20mM) for three 
generations. The videos were then analyzed using via WormLab software (MBF). Nine 
endpoints were chosen for analysis: track distance, wavelength, amplitude, maximum amplitude, 
forward and backward speeds, reversals, omega bends, and bending angles. Output data were 
exported to excel files for subsequent descriptive and analytic statistics.  
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Objective Two: To perform a systemic miRNA expression analysis coupled with target 
prediction analysis after direct nicotine exposure in L4 C. elegans belonging to the F0 generation 
(Chapter 3).  
Recently, accumulating evidence suggests the active role of epigenetic factors in gene 
regulation in response to environmental conditions. The epigenetic phenomena include non-
genetic diverse modifications from DNA and histone methylation to non-coding RNA expression 
patterns. However, to our knowledge, the effect of nicotine on miRNAs involved in addiction 
pathways has not been previously studied in C. elegans. Both objectives two and three were 
performed starting with RNA extractions, reverse transcription, and gene expression analysis via 
qRT-PCR. Finally, target prediction and pathway analysis were done using DAVID and GOrilla 
software. 
Objective Three: To determine suitable reference genes to be used in qRT-PCR normalization 
for transgenerational studies in C. elegans L4 exposed to nicotine (Chapter 4).  
Our results from the behavioral and molecular assays provided preliminary and 
potentially novel insights on nicotine’s mechanism of action. Based on the behavioral alterations 
and the complementary miRNA target predictions, future research will be concerned with 
investigations on protein target genes of interest. The latter will be performed via qRT-PCR 
which depends on the proper normalization to avoid false positive conclusions. Thus, we 
investigated the expression levels of sixteen reference gene candidates by qRT-PCR. The gene 
list was compiled from previous studies and was used to identify the most stable genes based on 
five approaches (geNorm, NormFinder, BestKeeper, deltaCt method, and RefFinder). Our 
objective will therefore contribute to the multi-level integrations to dissect nicotine’s mechanism 
of action on post-embryonic development and its inheritance.  
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Actions of nicotine in human body physiologies and systems 
CNS Arousal or relaxation  
Enhanced concentration, vigilance 
Appetite suppression 
Electroencephalographic changes 
Cardiovascular Increased heart rate, cardiac contractility, blood pressure 
Cutaneous vasoconstriction 
Systemic venoconstriction 
Increased muscle blood flow 
Catecholamine release 
Metabolic lipolysis with fatty acid release 
Increased energy expenditure 
Endocrine Increased growth hormone 
Adrenocorticotrophic hormone/cortisol 
Vasopressin 
Beta endorphins 
Inhibition of prostacyclin synthesis 
Table 1.1: A summary of the documented nicotine-dependent alterations in human physiologies and 
metabolisms (NIC 1992). 
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The potential 
adverse health 
consequences 
and symptoms 
of nicotine  
Nicotine 
intoxication 
Accelerated 
coronary and 
peripheral 
vascular 
disease 
Hypertension  
Stroke 
Delayed 
wound 
healing 
Reproductive 
or perinatal 
disorders (low 
birth weight, 
prematurity, 
spontaneous 
abortion) 
Peptic ulcer 
disease 
Figure 1.1: A summary of nicotine-associated symptoms in humans (NIC 1992). 
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Figure 1.2: A hypothetical model for time and concentration-dependent, differential, nicotine-induced AchR sensitization (Dani and Heinemann 1996). 
 25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: The lifecycle of C. elegans at 20
o
C. 0 min is fertilization. 40 minutes afterwards marks the first cleavage, while 150 minutes after 
fertilization is when eggs are laid at the gastrula stage. Numbers along the arrows indicate the length of time for each stage. The length of the 
animal at each stage is marked next to the stage name in micrometers (μm) (Adapted from (Altun and Hall 2009)). 
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Figure 1.4: Selection of nicotine concentrations based on dose-dependent nicotine effect on C. elegans speed as 
reported by Sobkowiak et al. (Sobkowiak, et al. 2011). ”Worms were tracked on plates with 0, 0.001, 0.01, 0.1, 1, 10, 
and 30 mM nicotine. In each experiment, worms were tracked for 30 s every 10 min. The treatment lasted 300 min. The 
mean speed was calculated from all collected data. Significance of differences from the control: *P < 0.01 and **P < 
0.05 (Kruskal–Wallis test) n ≥ 1461”. 
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Figure 1.5: Schematic representation depicting miRNA biogenesis pathway. Adapted from (O'Carroll and Schaefer 2013). 
  
Chapter Two: Nicotine exposure caused significant transgenerational 
behavior changes in C. elegans 
Abstract 
Passive and active exposure to tobacco smoking among youth is directly associated with 
immediate as well as long term health deterioration. Despite all pubic heath policies and efforts, 
the percentage of teenage smokers is still relatively high, especially in developing countries. 
Very few, if any, studies have been done on the trans-generational effect of nicotine exposed 
during the more sensitive, early developmental stages. We employed C. elegans as a biological 
model to study the multigenerational impact of chronic nicotine exposure. Nicotine treatment 
was limited to the N2 hermaphrodites of the F0 generation. It was strictly treated to L1-L4 (~31 
hours) period after which worms were transferred to a fresh NGM plate. L4 developmental stage 
was used for behavioral analysis across three generations: F0, F1, and F2. Our results show that 
nicotine was associated with changes in sinusoidal locomotion, speed, and body bends in L4 
larvae in all three tested generations. Despite having different patterns, those behavioral 
alterations were not restricted to F0, but were observed in F1 and F2 generations which were 
never exposed to nicotine. Our study is the first to reveal that nicotine addiction is heritable using 
C. elegans as a model organism. These results underscore the sensitivity of early development 
stages, with hope to spread more awareness to encourage the avoidance of nicotine exposure, 
especially at a young age. 
Key words: Nicotine, C. elegans, L4, post-embryonic stage, sensitivity to stress, trans-
generational effect, addiction, behavior 
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Introduction 
Nicotine is a tertiary amine composed of a pyridine and a pyrrolidine ring. In its non-
ionized form, nicotine can readily penetrate membranes (e.g. BBB). The major role of nicotinic 
receptors in nicotine’s mechanism of action has been established. Nicotine aversively affects 
several organs and systems (Table 1.1)  (NIC 1992). Its impact on the central and peripheral 
nervous systems contributes to the behavioral phenotypes in organisms (Benowitz 1988). This is 
primarily manifested in drug addiction symptoms such as compulsive drug seeking and taking 
behaviors (Le Foll and Goldberg 2009). Generally, nicotine-associated phenotypes are complex 
and depend of several factors such as dose, duration of exposure, and developmental stage 
(Hatsukami 2008).  As a psychoactive component of tobacco, nicotine abusers experience 
vomiting, tremors, convulsions, as well as depressant effects after initial exposure and even death 
at extreme doses (Dani and Heinemann 1996; Herberg, et al. 1993). Later, continuous use leads 
to tolerance as they adapt to nicotine-effects (Hatsukami 2008). The dependence becomes more 
evident in the drug seeking behavior and positive reinforcement (e.g. enhance the sense of well-
being, produce arousal or relaxation, help maintain vigilance, and reduce anxiety (Benowitz 
1988)) after drug taking. Individuals become addicted to nicotine and experience strong 
withdrawal side effects (e.g., teeth chattering, chewing, gasping, writhing, head shakes, body 
shakes, tremors, headache, nausea, constipation or diarrhea, falling heart rate and blood pressure, 
fatigue, drowsiness and insomnia, irritability, difficulty concentrating, anxiety, depression, 
increased hunger and caloric intake, increased pleasantness of the taste of sweets, and tobacco 
cravings) (Le Foll and Goldberg 2009) that promote being entrapped in a cycle of continuous 
nicotine use and relapses.  
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Early developmental stages as well as adolescence are  highly sensitive and vulnerable to 
nicotine (Ajarem and Ahmad 1998; Duncan, et al. 2009; Dwyer, et al. 2009; Hatsukami 2008; 
Leslie 2013; Wickstrom 2007). More so, children who are exposed to smoking are more likely to 
become addicted smokers as they progress to adulthood. Unfortunately about 40% of children 
are exposed to smoking in their environments (WHO 2012). Despite the increasing research on 
the effects of nicotine upon direct exposure and use, some studies have investigated a possible 
heritable effect of nicotine addiction (Heath, et al. 1995; True, et al. 1997) , but the latter only 
studied the relationship between genes and the environment in smoking susceptibility.  Other 
studies on nicotine transgenerational effects were concerned with nicotine exposure during 
embryonic and perinatal stages (Ajarem and Ahmad 1998; Holloway, et al. 2007). Due to the 
high incidence of tobacco smoking among teenagers and exposure among children (Kim, et al. 
2009; WHO 2012), we were interested in investigating possible long term consequences of early 
smoking habits. To our knowledge, no studies have been done on the transgenerational effect of 
nicotine exposed strictly during the post-embryonic and adolescent stages.  
Our choice of a model system was based on advantages detailed in Chapter 1 and can be 
summarized by the ease of maintenance, and ethical, behavioral and biotechnological 
investigations. In C. elegans, nicotine altered some behaviors such as egg laying, pharyngeal 
pumping, muscle contraction, and male spicule ejection (Matta, et al. 2007).  The invertebrate 
was able to recapitulate complex behavior associated with nicotine treatment in higher organisms 
such as acute response, tolerance, withdrawal, and sensitization (Feng, et al. 2006).  Recently, 
motivation and drug seeking behaviors were reported in experiments that measured the approach 
of pretreated worms based on a gradient chemotaxis experimental design (Sellings, et al. 2013). 
The vulnerability of the post-embryonic stages was also highlightes in a C. elegans study that 
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showed nicotine-dependent motivation in pretreated young worms in comparison to the older 
adult counterparts (Sellings, et al. 2013). Thus, we took advantage of the wealth of previous 
research on nicotine and C. elegans in our experimental design. The choice of nicotine 
concentrations was based on dose and time-response investigations by Sobkowiak et al. 
(Sobkowiak, et al. 2011) (Figure 1.4) which were complimented with addiction-related behavior 
assays done by Feng et al. and Sellings et al. (Feng, et al. 2006; Sellings, et al. 2013). 
Briefly, worms were exposed to nicotine strictly in the postembryonic stage (L1-L4) for 
about 30 hours. Subsequently, the behaviors of L4 larvae belonging to three generations: F0, F1 
and F2 were analyzed. Our study is the first to report the heritability of nicotine addiction 
starting from the post-embryonic stage.  
Methods and Material 
Nicotine exposure and sampling 
Nicotine was purchased from Acros Organics (New Jersey, USA). Nicotine was 
dissolved in phosphate buffer as 1 M and 0.001 M stocks. NaCl, peptone, agar and water mixture 
were first autoclaved and kept at 70 °C covered under the hood. Equal amounts were transferred 
to individual small autoclaved flasks cooled and kept at 55 °C. After the addition of cholesterol, 
CaCl2, MgSO4 and KH2PO4, nicotine solution was added to give the corresponding final 
concentrations 20µM and 20mM in the medium.  
C. elegans hermaphrodite N2 Bristol wild type was used. Maintenance and worm transfer 
were done after NGM plates were seeded with OP50, and then kept at 20
o
C. Egg synchronization 
was done via bleaching method described by Sulston and Hodgkin, with slight modifications 
(Sulston and Hodgkin 1988a). Briefly adult gravid worms were washed off the plate with M9 
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buffer into a 15 ml Falcon tube (for a medium sized pellet). Then the Falcon tube was 
centrifuged at 2000 rpm for 2 minutes to collect worm pellet and was followed by another wash. 
Then, 5 ml of synchronization solution was added for 5 minute-shake until the eggs were 
dispersed in solution. The eggs were pelleted after centrifugation at 2000 rpm for 2 minutes. The 
supernatant was removed and followed by four time wash using 5-ml M9 washes. The eggs were 
finally suspended in the last wash and were placed on a shaker in the 20
o
C incubator for about 14 
hours. After hatching, all progeny were stuck at L1. The latter were seeded onto corresponding 
treatment plates. 
Figure 1.2 shows the general protocol for worm treatment and sampling. F0- L1 larvae 
were transferred to the three treatment groups which included the control group along with the 
low and high nicotine concentrations. F0 exposure lasted around 31 hours until end of L3-
beginning of L4. Later, around 20 worms were then picked from each of 4 replicates into 4-
treatment matched 3.5cm petri-plates. The plates were previously seeded with OP50 and left to 
dry for subsequent behavioral studies. Worms were washed off the plates and transferred to an 
eppendorf tube. Then, the pellet was washed twice with M9 interrupted by centrifugation and 
supernatant removal. The worms were then transferred into OP50-seeded NGM plates, left to 
dry, and were sealed and placed back in the 20
o
C incubator to grow until second day of 
adulthood-associated with egg laying peak. Plates were washed for synchronization. The whole 
procedure was repeated twice until collecting the F2 generation. 
Two hours after the transfer, a 5-8 minute video was taken per replicate for every 
treatment group. The video was set at (15 frames/sec) with the same magnification for all 
treatment groups. The videos were then analyzed via Wormlab software (MBF bioscience). 
Output data included endpoints for every tracked worm (i.e. mean track length, mean 
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wavelength, mean amplitude, mean maximum amplitude, mean smoothed forward speed, mean 
smoothed backward speed, mean bending angle, omega bends, and reversals ratios). Video 
image noise was taken into consideration when choosing among the calculated speed indices. 
Image noise represent a signal detected during tracking and is generally not originating from the 
target (as in the case of uneven illumination). With the assumption that the target is associated 
with medium-sized features in comparison to noise, a smoothing approach reduces the small 
features while preserving the larger shapes. Smoothing is applied to remove the unwanted 
variation (Kan 2012). So, as done by Faumont, et al (Faumont, et al. 2011), the speed was 
calculated as the average instantaneous velocity over a specific time frame. With such rationale 
in mind, we chose smoothed speed to study the effect of nicotine on the locomotion velocity. 
Data Analysis 
Data provided by Wormlab software was exported to an Excel spreadsheet. Mean track 
length, wavelength, amplitude and maximum amplitude variable for each tracked worm were 
used from the track summary output. Each of the smoothed speed, bending angle, omega bend, 
and reversals ratios was calculated as the average/frame for each tracked worm. The smoothed 
speed was divided into positive (forward) and negative (backward) speeds. Both speeds were 
binned into intervals, and the number of worms with speeds falling in the right range was 
counted to get a frequency table. Contingency tables were used for speed statistical analysis. The 
Chi-square test was used for overall statistical significance, and the speed pairwise comparison 
among treatment groups was based on z-tests. As for the other endpoints, data from each 
individual worm was pooled from the four replicates per treatment group for statistical analysis 
via omnibus hypothesis testing one-way ANOVA. Statistical significance was reported when 
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P<0.05. Data analysis was done via SPSS (19). Each endpoint is defined based on Wormlab 
software as described in (Figure 2.2) (Bioscience 2012). 
Results 
The transgenerational impact of nicotine on locomotion 
In the F0 generation, the mean track length, amplitude, maximum amplitude, and 
wavelength, were significantly affected by direct nicotine exposure with F(2,460)=29.655; 
F(2,460)=52.635; F(2,460)=150.104; and F(2,460)=705.101 at P<0.001. A peak was observed 
for the low concentration treatment groups for the track length and maximum amplitude values 
(P=0.027). As the concentration increased, the values for all of the four endpoints significantly 
decreased (P<0.001) when comparing the high concentration (20mM) treatment groups to both 
control (0µM) and low concentration (20µM) treatment groups (Figure 2.3). In the following 
generations, for the most part, an increase was observed more noticeably in F1 after which it was 
diluted in F2. The F1 generation had statistically significant changes in track length 
[F(2,315)=3.619, P=0.028], maximum amplitude [F(2,315)=3.715, P=0.025], amplitude 
[F(2,315)=4.974, P=0.007] and wavelength [F(2,315)=7.206, P=0.001]. Post-Hoc pairwise 
comparison testing showed that the mean wavelength increased in both 20µM (P=0.001) and 
20mM (P=0.002) treatment groups when compared to control. A dose-dependent increase in the 
amplitude and the maximum amplitude was observed to summit in the 20mM treatment group 
(P≤0.007). Also, the track length and the amplitude were even noticeably greater than the 20µM 
treatment group (P=0.008 and P=0.022, respectively).  From F1 to F2, statistical significance 
was observed only in the wavelength [F(2,198)=4.913, P=0.016] where elevation was observed 
in both the low and high concentration treatment groups (P=0.012 and P=0.014, respectively). 
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Interestingly, though not statistically significant, all of the locomotion endpoints were higher in 
the nicotine treatment groups than control (Figure 2.3). 
Mutigenerational effects of nicotine on the dynamic body movements on C. elegans 
There was an opposing pattern between F0, and F1 and F2. In F0, the reversals decreased 
in a dose-dependent but not a statistically significant manner. However, both F1 and F2 reversed 
more. The stronger increase was seen in F1 [F(2,236)=3.939; P=0.021]. The 20mM treatment 
groups out-reversed the control (P=0.008) and 20µM treatment groups (P=0.021). In F2, the 
20mM treatment group continued to have more reversals than that of the lower nicotine 
concentration even at F2 (P=0.045) (Figure 2.4).  
A dose dependent decrease in the average bending angle was observed in F0 and F2. 
With an impact factor of F=39.336 at P<0.001, F0 worms exposed to high nicotine concentration 
bent with a smaller angle than control and 20µM treatment groups (P<0.001). From F0 to F1, 
worms exposed to 20mM nicotine continued to have a narrower bending angle than the 20µM-
exposed worms (P=0.034) (Figure 2.4). 
As for the omega bend, major differences were not observed in the 20µM treatment 
group. On the contrary, an increase was evident in the 20mM treatment group in all the 
generations. The increase was the strongest in F0 [F(2,460)=10.039], particularly in the 20mM 
treatment group when compared to both control and 20µM treatment groups (P≤0.001). The 
omega impact factor decreased in a generation-dependent manner to become F(2,315)=4.375; 
P=0.013 in F1. The increase was statistically significant with P=0.023 and P=0.004 when 
compared with control and 20µM -F1 groups, respectively. Despite the transgenerational 
depression in the effect, a dose-dependent increase was also observed in F2 with the 20mM 
treatment compared to control with P=0.027 (Figure 2.4). 
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The trans-generational effect of nicotine on speed in C. elegans  
Forward speed 
Nicotine exposure had the strongest impact on the F0 generation worm population on the 
overall forward speed among the treatment groups (χ2=68.707; P<0.001). Contrary to the 
distribution of the worm proportion for the 20µM treatment group which didn’t deviate with 
statistical significance from the control at any speed range, the 20mM worm proportion 
statistically differed from the control in 4 of the 5 speed ranges. Most of the 20mM-treated 
worms moved with forward speed falling in 0-20µm/s range. In the latter, our data reveal a 
([52.3:47.7:84.5] %) relative worm distribution among each of the control, 20µM, and 20mM 
treatment groups, respectively. Consequently, both the control and 20µM treatment groups had a 
higher worm frequency in the speed ranges: 20-40µm/s, 40-80µm/s, 80-160µm/s, >160µm/s. 
14.3% of the worms in the control, and 10.2% of the worms in the 20µM treatment group moved 
with speed range of 40-80µm/s. Only 1.7% of worms treated with the high nicotine 
concentration moved with that speed range.  A similar pattern was observed at the >160µm/s 
speed range. An average of 3.5% of the worms belonging to both control and the 20µM 
treatment groups moved with forward speed >160µm/s, while only 0.4% of worms belonging to 
the 20mM nicotine treatment group moved at that speed range (Figure 2.5). 
The impact on forward speed was robust as it was observed in the F1 generation 
(χ2=43.421; P<0.001). The frequency of worms, exposed to 20mM nicotine, continued to have a 
statistically significant peak ([19.8:12.4:53.6] %) in the 0-20µm/s range. The relative worm 
peaks for those exposed to 20µM nicotine showed a new set of proportions with statistically 
significant elevations ([19.8:24.7:8.9] %) and ([5.8:16.5:3.6] %) at speed ranges of 40-80µm/s 
and 80-160µm/s when compared to both control and 20mM groups (Figure 2.5).  
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The worm proportions versus speed range distribution became more similar among the 
treatment groups in the F2 generation. However, the proportion of worms treated with 20µM 
nicotine ([42.6:60.3:54.0] %) was statistically higher with respect to control at the 20-40µm/s 
while both the control and the high concentration treatment groups had more worms with higher 
speed ranges e.g. ([16.4:9.5:22.0] %) at the 40-80µm/s (Figure 2.5).  
Backward speed 
Nicotine exposure significantly affected the worm's backward speed on F0 generation 
(P<0.001). To state the statistically significant pairwise comparisons, around 76.6% of the 
20mM-treated worms belonged to the slowest speed range (0-20µm/s) when only 23.8% and 
35.2% of the control and 20µM-treated worms were in this range. Meanwhile, the difference in 
the peaks between control and treatment groups was statistically significant in the 20-40µm/s 
speed range ([45.2:26.1:20.0] %). Also, though not significant, another high proportion of worms 
was observed for the 20µM treatment group at the 40-80µm/s ([23.8:30.6:25.5] %). The 
proportion of the 20mM-treated worms decreased from 20.0 % to about 0.0-2.5 % in the faster 
speed ranges, three of which were statistically significant (Figure 2.5).  
Statistically significant differences in the worm proportions were also detected in the F1 
generation and that was limited to the high concentration treatment group. 34.5% of the 20mM 
treated worms had a 0-20µm/s speed range in comparison to the 18.6% 20µM treated worms. 
Another statistically significant difference was observed for the high-concentration treatment 
group (1.8%) at the 80-160µm/s speed range while the control and low concentration treatment 
groups had worm proportions of 10.7 and 14.4%, respectively, at that range (Figure 2.5).  
As for the F2 generation, though the worm proportion peaks became more alike and in 
the 20-40µm/s range ([38.3:40.7:34.7] %), the 20mM-nicotine-treated worms peaked with 
 38 
 
statistical significance at a faster range with 42.8% of its worms at the 40-80µm/s speed range 
while the 0µM and 20µM treatment groups had 25.0% and 32.2% of their worms in this speed 
range (Figure 2.5). 
Discussion 
Nicotine is a potent stimulant and a cholinergic agonist. There is no uniform standard 
molecular phenotype associated with nicotine as alterations in cholinergic receptors in the brain 
ranged from states like stimulation, inactivation, and increase or decrease in the turnover rate of 
nicotinic receptors on the cell membranes. Its action is therefore not only context-dependent, but 
it is also based on the dose and duration of its exposure (Schafer 2002). In C. elegans, it has been 
documented that nicotine treatment is associated with hyper-contraction of body wall-muscles, 
stimulation of egg laying, increased pharyngeal pumping as well as a decrease in the efficiency 
of male spicule in mating (Matta, et al. 2007; Schafer 2002).  
We were interested in studying the addictive nature of nicotine. With smoking being so 
prevalent in regions like the Middle East (e.g. Lebanon), the chances of persistent nicotine 
exposure among the younger groups remain high. Early developmental stages have been proven 
to be more sensitive to any sort of stresses such as nicotine exposure. Of notice, the highest male 
to female-teenage smokers was reported in Lebanon, a 66:54% in 2005-2010 (WHO 2012). It 
was reported that even a limited nicotine exposure during adolescence may lead to symptoms of 
dependence and that this sensitivity might be due to the neurochemical changes in the brain that 
is different from those of adults (CDC 2010; Slotkin 2002). We were interested in assessing the 
extent of the nicotine-induced alterations. We wanted to explore if effects caused by early 
development nicotine exposure would be passed on to the offspring. Thus, nicotine exposure was 
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limited to the L1-late L3/early L4 period. Hence, adult hermaphrodite worms and the subsequent 
F1 and F2 generations were never in direct contact with nicotine. 
Understanding the patterns and relationships in our data 
Speed can be calculated as wavelength x oscillation frequency. Therefore, the wavelength 
and the speed are directly proportional. That is consistent with our data for the F0 generation 
where a decrease in speed in the 20mM group was associated with a decrease in wavelength. 
Also, in F1 and F2 generations, both the forward speed and the wavelengths increased.  
The omega bend is summarized in 3 steps: With reference to the body centroid point, the 
worm has a bending angle <90
o
. Then, the worm bends to less than 45
o
. The omega bend ends 
with the worm opening its body with a bending angle >90
o
. Hence, one would expect that there 
is an inverse relationship between omega bend and bending angle (Figure 2.4). 
F0 generation models direct nicotine toxicity, and addiction (tolerance) 
The high concentration treatment group modeled nicotine-induced toxicity as it was 
negatively affected in all the locomotive indices. Their movement remained confined to a small 
area as evident in the lower track length, and had lower wavelengths and amplitudes. Also most 
of the worms had minimal forward and reverse speeds (0-20µm/s). Thus the 20mM treated 
worms seemed paralyzed, and that is in agreement with previously reported results (Sobkowiak, 
et al. 2011). Having said that, the increase in bends might not specifically reflect the omega 
bends. It seemed as if the worms were unable to free themselves and appeared to be in coiled 
structures (data not shown). The latter could have been mistakenly detected as omega bends by 
the software. The decrease in amplitudes in the 20mM may support this conclusion as it is 
reasonable to expect a directly proportional relationship between omega bend and amplitudes.  
 40 
 
Nicotine is involved in locomotion stimulation when applied acutely. The stimulating 
effect is evident when applied in a specific concentration range. The 20µM treatment group falls 
within this range (Sobkowiak, et al. 2011). However, no increase in forward speed was detected. 
One difference in the experimental settings was the duration of nicotine application. Therefore, 
the “apparently” normal speed may represent chronic nicotine tolerance and adaptation which 
has been previously documented (Feng, et al. 2006). However, the worms did show a faster 
negative speed. Such indicated a faster reversal movement and is logical with the AVA 
command neurons, which regulate reversals, being a nicotine target (Chalfie, et al. 1985; Feng, et 
al. 2006; Von Stetina, et al. 2006; Zheng, et al. 1999). In normal food-replete conditions, worms 
tend to be “dwelling”-a behavior with frequent reversals and increased turn angles and lower 
forward speed. This was not totally observed in our case since the forward speed for the 20µM 
group was not lowered. Instead, the worms performed fewer reversals and more omega bends. 
The F1 and F2 generations modeled inherited toxicity and addiction (withdrawal) 
The effect of nicotine on the forward speed 
Overlaying the speed curves allowed us to see two major peaks in the F1 generation 
worm population. The control (0µM) and 20µM treatment groups had most of their worms 
moving in the 20-40µm/s range. Overall, 45.3% of the 20µM treated worms were faster than 
those in the control (31.4%). As for the 20mM treatment group, the peak was in the 0-20µm/s 
speed range. However, unlike the case in the F0 generation, we can notice the absence of any 
statistically significant difference in comparison to the 0µM treatment group. Hence, in the F1 
generation, more 20mM-nicotine-treated worms moved with higher forward speed. Thus, their 
behavior is becoming closer to the wild type untreated worms. 
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Reaching the F2 generation, all of the treatment groups peaked at the same speed range 
(20-40µm/s) with the 20µM group having the largest worm proportion. On the other hand, taking 
into consideration the highest four speed ranges, it seemed that the highest worm proportion 
belonged to the 20mM-treatment group (80%), which is close to that of the 20µM (79.4%), and 
the least was that of the control (68.8%) treatment groups.  
The effect of nicotine on backward speed 
We previously described a three-peak-speed-pattern in the F0 generation worm 
population occurring in the 20µM treatment group which reversed faster than 0µM and the 
20mM treatment groups, respectively. 77% of worms treated with the 20mM nicotine 
concentration moved at the 0-20µm/s speed range, while only 34% of their offspring in the F1 
generation worm population moved at that speed. This proportion remained almost the same in 
the two successive faster speed ranges (33%, 29%, respectively). From a bird’s eye view, it 
seems that two peaks appeared for F1. Most of the worms in the low and high nicotine treatment 
groups reversed with 40-80µm/s speed, while those of the control group reversed with a slower 
speed (20-40µm/s). Thus, the 20mM treated worms became far from paralyzed, as was observed 
in the F0 generation, and seemed to be catching up with by increasing their reversing speed.  
The pattern seems to get exacerbated in the F2 generation, as the proportion of worms 
treated with nicotine high concentration peaked at the faster speed 40-80µm/s in comparison to 
both the control and the low concentration treated worms. The latter two had similar patterns 
across the speed ranges. 
Withdrawal serves as a better index than tolerance (CDC 2010). Both nicotine-dependent 
and nicotine non-dependent smokers did not differ in tolerance after being exposed to it. 
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However, they differed significantly with their behavior during nicotine abstinence (CDC 
2010).Interestingly, the phenotypes observed in the F1 and F2 generations may be models of 
withdrawal since worms were grown on fresh NGM all along, but still exhibited altered speed 
(Schafer 2002). The hyperactive behavior can be reflective of craving or uneasiness in worms as 
they are no longer getting their addicting and satisfying nicotine dose. Looking at our data, we 
suspect that this addicting dose (that is not associated with direct toxicity) is around that of the 
low concentration (20µM range) as evident in the F1 individuals. It is expected that an effect 
might be diluted across generations. Progressing from the F1 to the F2, there was a 
dilution/amelioration in the 20mM nicotine toxic paralyzing effect, until it became comparable to 
that induced in the 20µM range. Eventually, the progeny of the 20mM treated parents had the 
highest speed (most anxious) in the F2 generation. We can deduce that the higher the parental 
exposed concentration, the further down the effect is tracked and inherited.  
Omega and reversals and overall locomotion indices in response to nicotine treatment 
Three behavioral patterns are defined for C. elegans as a function of food supply. When 
food is present, short reversals and infrequent omega bends occur. When transferred to a food-
free- medium, long reversals, frequent omega bends, and an increase in forward speed are 
observed. The third pattern is seen after longer periods of food abstinence, when both reversals 
and omega bends decrease to allow the worm to seek food. In short, the omega bends are 
generally proportional “coupled” to reversals-though the opposite is not a prerequisite (Gray, et 
al. 2005; Wakabayashi, et al. 2004). However, our data does not fully support this. In the F0 
generation, the relationship between reversals and omega bend is opposite and this pattern was 
dose dependent to become statistically significant at 20mM treatment group. It is noteworthy to 
mention that this behavior was specific to the F0 individuals which were in direct nicotine 
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exposure. The pattern was different in the F1 and F2 generations, both of which were not 
exposed to nicotine and modeled withdrawal. It is important to exclude any biased interpretations 
to nicotine specific, addiction independent, symptoms.  
In the F1 and F2 generations, both the omega bends and reversals only differed in the 
high concentration treatment group. Though they were “coupled”, it still didn’t model the normal 
situation where omega bends should have been infrequent due to the availability of food as seen 
in the control. Though the omega bends did increase in the three generations, the omega bends 
occurring in the F0 individuals had less amplitude than control and may therefore not be true 
omega bends, while those in the F1 and F2 individuals were more vigorous with increasing 
amplitude in comparison with control. It is documented that when the environment is declining, 
the frequency of reversals and sharp turns increases, and vice versa (Gray, et al. 2005). Such may 
pinpoint that the worms were not comfortable in the normal settings, and perhaps they were in a 
“craving” status. The latter point can be complimented by the conclusion provided by Zhoa et al. 
(Zhao, et al. 2003). They considered reversals as a way that allows the worm to constantly 
reassess its priorities (i.e. as reversals were initially a way of avoidance from harsh contact and 
later became a way of foraging). Hence, this shift in behavior is reflective of withdrawal 
symptoms and might insinuate the inheritance of nicotine addiction. 
Logically, the alterations in reversals and body bends point to the effect of nicotine on 
particular neurons. It has been documented that the AVA neuron is involved in reversals, while 
the SMD, RIV, and SMB are involved in omega bends and regulation of its amplitude (Gray, et 
al. 2005). It would be interesting to dissect the cellular pathways involved in the response to 
nicotine. Whether it majorly involves acetylcholine receptors as upstream effectors or its acts 
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directly on different effectors (e.g. serotonergic system) in a cell-type specific manner is worth 
further studying. 
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Figure 2.1: Description of nicotine exposure on C. elegans hermaphrodites and sampling for assays of 
interest. 
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Track length The additive distance travelled from one frame to another. 
Wavelength Distance between negative and positive inflection points 
Amplitude The average centroid displacement over the entire track.  
The blue dot is the default average median axis. The green dot is the center 
  location of the median axis
Maximum amplitude The maximum centroid displacement over the entire track. 
Smoothed Speed A three-frame moving average speed smoothed over a 20 second span. The 
moving average speed is the instantaneous velocity along the worm’s 
central line averaged over a number of frames. 
Bending angle The angle between the centroids of both the head and the tail. 
Omega bend Occurs when the worm makes an omega-shaped movement. 
   
   
Figure 2.2: Summary of endpoints definitions as analyzed by the Wormlab MBF software. 
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Figure 2.3: An overview of the variation in the different endpoints’ pattern as a function of nicotine dose on L4 hermaphrodite C. 
elegans across the three generations. From left to right, bars represent F0, F1, and F2, respectively. The x-axis represents nicotine 
concentrations used. Control is the group without nicotine. (P*)≤0.001. 
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Figure 2.4: An overview of the variation in the patterns of body bends and reversal behavior in L4 hermaphrodite C. 
elegans as a function of nicotine dose across the three generations. BA: Bending angle; OB: Omega bend; R: 
Reversals. In the bar graphs, bars from left to right represent F0, F1, and F2 generations, respectively. Pairwise 
comparisons were performed among treatment groups within same generation. (ab), (AB), (αβ) are for F0, F1, and F2, 
respectively. Different letters correspond to statistically significant differences. (P*)≤0.001. 
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Figure 2.5: The impact of nicotine on the forward and backward speed (um/s) in L4 C. elegans hermaphrodites. 
The y-axis represents a ratio calculated from the proportion of worms in each treatment group normalized to 
control.  (©) represents P<0.05 with respect to control. (@) represents P<0.05 with respect to the other nicotine 
treatment group. It represents a ratio calculated from the proportion of worms in each treatment group 
normalized to control. The x-axis represents speed (um/s) divided into 5 ranges. 
 
  
Chapter Three: Chronic Nicotine Exposure Systemically Alters MicroRNA 
Expression Profiles during Post-embryonic Stages in C. elegans 
 
Abstract 
Tobacco smoking is associated with many diseases including addiction, which is of the most 
notorious. The tobacco dependence is mostly attributed to nicotine, which is considered one of 
the most addictive chemicals. In our study, we chose C. elegans as a biological model to 
systemically investigate the effect of chronic nicotine exposure and their regulated biochemical 
pathway. Nicotine treatment (20µM and 20mM) was limited to the post-embryonic stage from 
L1-L4 (~31 hours) period after which worms were collected for genome-wide miRNA profiling. 
Our results show that nicotine significantly altered the expression patterns of 40 miRNAs. The 
effect was proportional to the nicotine dose and was expected to have an additive, more robust 
response. Based on pathway enrichment analysis coupled with nicotine-induced miRNA 
patterns, we inferred that miRNAs as a system mediates “regulatory hormesis”, manifested in 
biphasic behavioral and physiological phenotypes.  We proposed a model where nicotine 
addiction is mediated by miRNAs’ regulation of fos-1 and is maintained by epigenetic factors. 
Thus, our study offers new insights for a better understanding of the sensitivity of early 
developmental stages to nicotine. 
Key words: nicotine, miRNA, C. elegans, dose-dependent, redundancy, addiction, regulatory 
hormesis, biphasic response, post-embryonic exposure 
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Introduction 
Serious research has been devoted to dissect the factors involved in gene regulation and 
has provided clues concerned with the environmental contribution in shaping physiological 
phenotypes. MicroRNAs are an extensive class of newly discovered small regulatory RNAs. 
Over 200 and 1000 miRNAs have been sequenced in C. elegans and Humans, respectively. Due 
to their conserved and pleiotropic roles in gene regulation processes ((Ambros 2003; Aukerman 
and Sakai 2003; Chen, et al. 2004; Kim 2005; McManus 2003), miRNAs are considered 
biomarkers of an innate response to environmental fluctuations. Several studies have reported 
nicotine-induced alterations of miRNAs in different biological systems (e.g. PDLSC (Ng, et al. 
2013), mouse fetal neuroepithelial precursors (Balaraman, et al. 2012), rodents and PC12 cell 
model (Huang and Li 2009), canines (Shan, et al. 2009), humans (Kassie, et al. 2010; Shin, et al. 
2011)) (Table3.1) . Nicotine-induced miRNA alterations were associated with its negative effect 
on stem cell regeneration (Ng, et al. 2013). It was a tumorigenic agent as it upregulated 
oncogenic miRNAs (e.g. miR-16nd miR-21) in AGS cells (Shin, et al. 2011). Nicotine also 
antagonized and upregulated ethanol-induced miRNAs (Balaraman, et al. 2012). Interestingly, a 
study done by Huang and Li demonstrated the role of miR-140* in nicotine addiction using 
rodents and PC12 cells. The researchers showed that miR-140* targeted dynamin, the latter of 
which is crucial for neuronal plasticity and hence addiction-related processes (Huang and Li 
2009). Taken collectively, these studies show a role or miRNAs in nicotine-dependent 
mechanisms. We were interested in investigating molecular mediators of nicotine-addiction in 
the larval stage in C. elegans. MicroRNA research is still in the juvenile stages, thus preliminary 
studies would follow a top-to-bottom approach to study the effect of nicotine on the global 
miRNA profile. Broad approaches like the latter provide more specific information about 
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miRNAs that were more highly altered in response to nicotine. To our knowledge, no previous 
study has been done on the impact of nicotine on the systemic miRNA expression in L4 C. 
elegans (N2). Our study offers new molecular insights related to the vulnerability of post-
embryonic stages to chronic nicotine exposure. The systemic miRNA profiling was coupled to 
target enrichment analysis funneled down our interpretation to specific pathways that might be 
relevant to nicotine’s mechanism of action. Our aim is to identify possible miRNA patterns that 
are linked to nicotine-induced behavioral (e.g. addiction) and protein disorders (e.g. receptor 
desensitization).  
Material and Methods 
Chemicals and Strains 
Purified nicotine was purchased from Acros Organics (New Jersey, USA). 1 M and 0.001 
M stocks were prepared by diluting nicotine in phosphate buffer. Nicotine solution was 
introduced to molten NGM agar (Stiernagle 2006) before being poured onto plates. NaCl, 
peptone, agar and water mixture were first autoclaved and kept at 70 °C covered under the hood. 
Equal amounts were transferred to individual small autoclaved flasks cooled and kept at 55 °C. 
After the addition of cholesterol, CaCl2, MgSO4 and KH2PO4, nicotine solution was added to 
give the corresponding final concentrations 20µM and 20mM in the medium.  
C. elegans hermaphrodite N2 Bristol wild type was used. Maintenance and worm transfer 
were done after NGM plates were seeded with OP50 and left to dry (around 10-15 minutes), and 
then kept at 20
o
C. E. coli stocks were stored as an LB pellet at -20
o 
C.  
Egg synchronization was done via bleaching according to a standard method with slight 
modification (Sulston and Hodgkin 1988b). Briefly, adult gravid worms were washed off the 
plate with M9 buffer into a 15 ml Falcon tube (for a medium sized pellet). Then the Falcon tube 
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was centrifuged at 2000 rpm for 2 minutes, respectively. The supernatant was then removed 
leaving the pellet. The wash was then repeated with 5 ml M9 followed by centrifugation and 
supernatant removal. Then, 5 ml of synchronization solution was added. The tube was shaken for 
4 minutes until the adult worms burst leaving the eggs dispersed in solution (a maximum of 4-5 
minutes in bleach solution). The tubes were then spun at 2000 for 2 minutes. The supernatant 
was removed and three to four 5-ml M9 washes followed leaving the last wash without 
centrifugation. The tubes with the suspended eggs were placed on a shaker in the 20
o
C incubator 
for 14-18 hours maximum (to avoid starvation). After hatching, the progeny were all stuck at L1. 
The latter were seeded plated onto treatment plates accordingly supplied with fresh OP50. 
Exposure lasted around 31 hours until end of L3-beginning of L4. 
miRNA expression profile 
Total RNA extraction was performed for all treatment groups according to protocol using 
mirVana™ miRNA Isolation Kit. Briefly, the sample was denatured using a lysis buffer. RNA 
was then separated from DNA and other proteins via acid-phenol extraction. Then, ethanol was 
added to the sample followed by centrifugation to allow it to pass through a glass-filter. Several 
washes preceded the elution of the RNA with DNase/RNase-free water. RNA quantification and 
evaluation was done using the NanoDrop ND-1000 Micro-Volume UVVis Spectrophotometer 
(NanoDrop Technologies, Wilmington, DE).  
Reverse transcription was performed using TaqMan microRNA Reverse Transcription kit 
(Applied Biosystems, Foster City, CA) to reverse transcribe extracted RNA to cDNA for all 231 
miRNAs . A total of 200ng of RNA was used for each RT reaction. The reactions were then run 
using thermal cycler for 16
o
C for 30 min followed by 42
o
C for 30 min, 85
o
C for 5 min and was 
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finally held at 4
o
C. The samples were then diluted in 80µL DNase/RNase-free water for qRT-
PCR. 
The expression levels of miRNAs were analyzed after performing qRT-PCR on 384-
well-plate using the ViiA
TM
 Real-Time PCR System (Applied Biosystem). Briefly, each well 
carried a 15µL reaction of 5.5µL DNase/RNase free water, 7.5µL SYBR Green master mix, 1µL 
diluted cDNA, 1µL primer mix. A minimum of 3 biological replicates were used. The reaction 
was carried out for 10 min at 95
o
C for enzyme activation followed by denaturation for 15 sec at 
95
o
C and an annealing/extension step for 60 sec at 60
o
C. The latter 2 steps were repeated for 40 
cycles.  
The Ct values from the qRT-PCR were exported to an excel file. The average of the total 
miRNA (231) Ct-values was used for normalization. The delta Ct (∆Ct) values were calculated 
as Ct(miRNA)-Ct(avg miRNAs). The delta delta Ct (∆∆Ct) was calculated as the difference in the ∆Ct 
values between control and treatment. Then the fold change was calculated as 2
(∆∆CT)
. Statistical 
analysis was based on t-test for independent samples via SPSS(20). The results were further 
narrowed based on two criteria. Only the genes whose expression changed with a P<0.05 and a 
fold change≥0.5, when compared to control, were considered as differentially expressed and 
were subjected to further analysis.  
Fold change values (2
(∆∆CT) 
-1) were used to construct heat maps coupled with non-
supervised hierarchical clustering using Euclidean distance and single linkage analysis and 
included all genes and samples. The latter approach was done for both total miRNAs as well as 
miRNAs that underwent statistically significant expression alterations using MeV 
(MultiExperiment Viewer) (AI, et al. 2006; Schmittgen, et al. 2008).  
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Target prediction and pathway analysis 
miRNAs that showed fold changes higher than ±1 were used to perform target prediction 
using mirSOM software (Heikkinen, et al. 2011). To prepare the input for analysis, duplicates 
were removed and thus only unique values of targets with perfect seed match were used. The 
predicted targets were ranked according to the frequency of occurrence in the originally 
compiled gene list. Such a frequency reflects the number of miRNAs predicted to target a gene. 
The list was used as input for DAVID (Huang, et al. 2009a; Huang, et al. 2009b) for analysis. 
Gene ranking was based on functional annotation clustering (highest stringency) provided by 
DAVID. Target genes belonging to clusters with enrichment values ≥2 were used based on the 
order of the clusters to prepare a ranked list. The latter included 321 genes and was used as an 
input for GOrilla (process ontology) (Eden, et al. 2009). GOrilla provided DAG (directed acyclic 
graph) showing relationships among enriched processes. miRNA-target networks were 
constructed using cytoscape (Smoot, et al. 2011). 
Results 
Genome-wide miRNA expression profiling 
We studied the effect of nicotine on the expression levels of 231 miRNAs in L4 C. 
elegans (N2). The average of the total miRNA expression remained constant between control 
and each treatment group (Figure 3.1A). Thus, it was considered for normalization of the Ct 
values for the 231 miRNAs. Fold change values were calculated in comparison to control and 
were used to construct a heat map. After performing unsupervised hierarchical clustering, the 
high concentration treatment groups clustered together (Figure 3.1C). On the other hand, the low 
concentration treatment groups were ordered next to each other without being clustered. 
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Complimentarily, the expression graphs of all miRNAs across treatment groups showed less 
variation in worms treated with the higher nicotine concentration in comparison to those treated 
with the lower one (Figure 3.1B). 
We investigated if nicotine was associated with a statistically significant alteration in the 
miRNA patterns. As explained above, miRNAs whose expression changed by more than 0.5 
folds with (P<0.05) were considered. In total, nicotine affected the expression of 40 miRNAs 
(17.3%) whose expression changed significantly and was consistent within and between control 
and treatment groups (Figure 3.1B). Then, the same unsupervised hierarchical clustering was 
performed coupled with leaf optimization for both miRNAs and samples (Figure 3.1D). We 
noticed that the upper-limit distance for sample clustering decreased by about 31% due to the 
decrease in inter-sample variations. Similarly, groups exposed to the high nicotine concentration 
clustered together, while those exposed to the lower concentration still showed more variation 
and were therefore only closely ordered.  In addition, taking the 1.39 distance as a cutoff, the 
miRNAs were binned into two major clusters. The smaller one included 8 miRNAs (mir-1820, 
mir-358St, mir-55, mir-259, mir-235, mir-58, mir-1821, and lin-4). The remaining miRNAs 
belonged to the second bin except for mir-2220 that clustered separately. Opposite patterns were 
characteristic of the two clusters. MicroRNAs belonging to the larger cluster were mostly 
upregulated (red color) in the worm groups exposed to the higher nicotine concentration 
(20mM), while they were variable in the lower nicotine treatment groups. Also, miRNAs 
belonging to the smaller cluster were more downregulated in response to higher nicotine 
treatment than they were in response to the lower nicotine concentration.    
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Quantitative assessment of differentially regulated miRNAs 
Three miRNAs were altered in response to the lower nicotine concentration (20µM). 
MiR-80 and miR-79 were upregulated by 1 (P=0.045) and 0.9 (P=0.022) fold, respectively. 
Conversely, the expression of miR-230* decreased by 0.5 fold (P=0.019). On the other hand, the 
expression of thirty eight miRNAs changed with statistical significance in worms treated with 
high nicotine concentration (20mM). The fold changes and p-values are shown in (Table 3.2).  
About 78% of the altered miRNAs were upregulated with fold changes ranging from 0.5 to 3 
folds. The most upregulated miRNAs were  miR-2220 with 3.4 fold change (P=0.034) followed 
by mir-90 (P=0.045) and mir-2210 (P=0.03) with >1.5 fold change. Other miRNAs, such as mir-
47* (P=0.027), mir-2216* (P=0.034), mir-49 (P=0.019), mir-38 (P=0.004), mir-255(P=0.003), 
mir-1829b (P=0.037), mir-785(P=0.003), mir-241 (P=0.017) and mir-242 (P=0.035) were up-
regulated by at least 100%.The remaining 22% miRNAs that were affected by the 20mM 
nicotine treatment were downregulated by 30% to 50%. The most downregulated miRNAs were 
mir-58 (P=0.014) followed by mir-1821 (P=0.03) and lin-4 (P=0.002) (Table 3.2). In addition, 
miR-80 was the only miRNA upregulated in both low and high nicotine concentrations (Figure 
3.2).  
Functional analysis of differentially expressed miRNAs through target prediction and 
biochemical pathways analysis  
Systematic miRNAgene predictionpathways 
To investigate the potential function of these differentially expressed miRNAs in 
response to nicotine, we performed miRNA target prediction coupled with enrichment analyses 
based on two online software, DAVID and GOrilla. 13 miRNAs, with ≥ ±1 fold changes, were 
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used for target prediction. The number of gene targets varied among those miRNAs from tens to 
hundreds. In decreasing order, mir-47* was predicted to target 549 genes followed by mir-785 
(521), mir-80 (501), mir-255 (265), mir-241 (224), mir-90 (167), mir-2220 (148), mir-2210 
(140), mir-49 (127), mir-1829b (89), mir-38 (72), mir-242 (55), and mir-2216* (19) (Figure 
3.4B). A unique list of 2395 genes was used as input for DAVID analysis. After functional 
annotation clustering, a ranked list of 321 genes was prepared based on the decreasing order of 
clusters with enrichment values ≥2.  
DAG computed by GOrilla showed the enrichment of 5 major hubs (Figure 3.3). The 
“biological regulation” (1.6, P<10-5), was generally divided into a molecular level summarized 
by metabolic and biosynthetic processes (e.g. RNA) and gene regulation (e.g. transcription). The 
second sub- level covered cellular and behavioral phenotypes such as neurogenesis and 
locomotion and location, respectively. Another major hub involved “response to stimulus” (2.3, 
P<10
-5
) which was linked to neuro-related pathways through taxis. The highest enrichment was 
reported for immunity (56.8, P<10
-5
) and was mainly reflected by response to other organisms 
(i.e. fungus). Also, one of the upstream nodes was “cellular process” (1.11, P<10-5) and it 
branched to include growth, development, projection and organization, and recognition (e.g. 
axon guidance). The highest statistical significance was observed for “metabolic process” (1.17, 
P<10
-7
) which comprised protein and phosphate-related modifications, single organism 
processes, and primary metabolism.  
Enriched processesgenesmiRNAs 
A bottom-top approach was then used to check the involvements of each of the 13 miRNAs in 
the enriched processes. Hence, we extracted the genes involved in 94 pathways outputted in 
GOrilla with p-values < 10
-3
 (Figures 3.3 and 3.4). Then, we overlapped them with the predicted 
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targets for each of the 13 miRNAs. miR-47* was the only miRNA predicted to target genes 
belonging to all of the 94 pathways. In decreasing order, mir-80, mir-255 and mir-241 covered 
93%, 85%, and 82% of the processes and had a similar involvement pattern that did not include 
some cellular processes (e.g. recognition, migration, development, growth). A slightly different 
pattern was observed for mir-785 and mir-2220 which covered 75% and 62% of the pathways, 
respectively, but were not involved in immunity and development.  The situation was the same 
for mir-38 (62%) and mir-90 (57%), but both were also less involved in response to stimulus. 
Four of the remaining miRNAs [mir-49 (37%), mir-2210 (32%), mir-1829b (18%), and mir-242 
9%)] were not predicted to target genes involved in the nucleotide metabolism and biosynthesis 
or gene regulation. Instead, the target genes were more concentrated around protein metabolism 
and modifications as well as response to stimulus. Finally, mir-2216* did not show any match 
with any of the functions.  
Commonly targeted genes 
Network construction for all the 13 highly altered miRNAs with the total target list 
revealed a very complex network as seen in (Figure 3.5A). A simpler network was obtained after 
considering only the 13 commonly targeted genes (Figure 3.5B). Based on the originally 
compiled unique target list, only F40F11.2 (0.04%) was predicted to be targeted by 5 miRNAs. 
0.5% of the genes were commonly targeted by 4 miRNAs, while 2% and 14% were common 
targets for only 3 and 2 miRNAs, respectively. Only the genes targeted by at least 4 miRNAs 
were used in network construction. From the most to least involved, mir-47* was predicted to 
target all 13 genes. Mir-785 targeted all except for B0336.3. All of the 8 genes targeted by mir-
241 (B0336.3, C48A7.2, ceh-44, fos-1, let-75, ptc-1, sem-4, and tag-97) were common to mir-
255. The latter also targeted F10D2.10 for a total of 9 genes. Also, ain-2, F40F11.2, sax-3, and 
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tsp-14 matched with mir-2210, whereas 1829b had only 3 and did not include F40F11.2. Finally, 
mir-80 matched with only one gene (B0336.3), while mir-49 and mir-242 targeted F40F11.2 and 
F10D2.10, respectively. Together, they comprised an intricate network as shown in Figure 3.5B. 
Complimentarily, we ran functional annotation via DAVID which summarized all functions 
associated with the genes of interest. The 13 genes were concerned with four major ontologies: 
development and growth, reproduction, metabolism and transcriptional regulation (Table 3.3).  
Five major enriched functional hubs 
GOrilla enriched for five major hubs that can be summarized as: biological regulation, 
response to stimulus, immune processes, cellular and metabolic processes. After overlapping 
miRNA-target genes with the corresponding functional hub, we constructed a network that 
depicted the relationship between most of the highly regulated miRNAs with enriched nicotine-
induced biological pathways. The network reflected a “nicotine-butterfly effect”, where most 
miRNAs were involved in the metabolic processes, while more specific miRNAs were involved 
in regulation of immune response (Figure 3.5C). 
Discussion 
Nicotine is a potent stimulant and a cholinergic agonist. There is no uniform standard 
molecular phenotype associated with nicotine. Its action is therefore not only context-dependent, 
but is also based on the dose and duration of its exposure (Schafer 2002).With smoking being so 
prevalent in countries in the Middle East (e.g. Lebanon), the chances of persistent nicotine 
exposure among the younger groups remain high. Of notice, the highest ratio for male: female 
teenage smokers reached 66:54% in 2010 (WHO 2012). Early developmental stages are more 
sensitive to any sort of stresses. When considering nicotine, the case is not different. It is 
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reported that even a limited nicotine exposure during adolescence may lead to symptoms of 
dependence and that this sensitivity might be due to the neurochemical changes in the brain that 
is different from those of adults (CDC 2010; Slotkin 2002). Consequently, children exposed to 
nicotine are more prone to become smokers when they grow up, therefore initiating a vicious 
cycle of nicotine usage. We were interested in assessing the extent of the nicotine-induced 
alterations on simpler organisms such as C. elegans that enables extrapolations to higher 
organisms. In C. elegans, it has been documented that nicotine treatment is associated with 
hyper-contraction of body wall-muscles, stimulation of egg laying, increased pharyngeal 
pumping as well as a decrease in the efficiency of male spicule in mating (Matta, et al. 2007; 
Schafer 2002). However, no previous studies have investigated the impact of nicotine on the 
genome-wide miRNA profile. In our study, we limited nicotine exposure to the post-embryonic 
stage and investigated miRNA patterns as well as target predictions and networks occurring in 
the L4 stage in response to nicotine. Here we report that nicotine altered the expression of 17% 
of total miRNAs, most of which (78%) were dramatically upregulated in response to high 
nicotine concentration. Also, the degree of statistically significant upregulation ranged between 
0.5 and 3.4, while that of the downregulation was less than 1 fold in both treatment groups.  
Comparison between nicotine-induced behavioral versus miRNA responses 
From the behavioral perspective, it has been reported that different nicotine 
concentrations and exposure durations correlated with a “biphasic” response in the treated 
organisms. The mean speed increased in worms exposed to lower nicotine concentrations (10-
100µM). On the contrary, the mean speed decreased when exposed to higher nicotine 
concentrations (10-30mM) (Sobkowiak, et al. 2011). Nicotine psychopharmacologic effects can 
stimulate or depress a variety of processes (e.g. central and peripheral nervous, cardiovascular, 
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endocrine systems) (USDHHS 1988). All together were summarized as dose-dependent 
psychoactive effects (Shadel, et al. 2000) ranging from skeletal muscle relaxation, increases in 
brain serotonin and pituitary hormone, etc. (USDHHS 1988) to symptoms like tremor, nausea, 
and weakness (Benowitz 1988). How does that overlap with molecular level alterations? 
Unlike the behavior, the increasing nicotine doses did not cause an inverse miRNA 
expression pattern. However, the degree of fold change (1 versus 3.4 fold) as well was the 
number of altered miRNAs (1.3% versus 16.4%) increased with increasing nicotine 
concentrations. Such a dose-dependent response was also manifested in the heat map after 
hierarchical clustering by distinct color gradients for mir-2220 and the two other multi-miRNA 
clusters (Figure 3.1CD). Thus, the molecular miRNA response was proportional and can 
generally be approximated as hyperbolic as a function of nicotine dose.  
Understanding the molecular basis of nicotine-induced behavior  
The relation between molecular and behavioral levels can be described as “regulatory 
hormesis”. In normal conditions, homeostasis prevails in an organism. After lower exposure of a 
stressor, it responds with moderation. Such an intermediate level of regulation (e.g. regulatory 
miRNAs) can be associated with a stimulatory or a beneficial phenotype. However, as the 
stressor increases, the regulative response is inflated and could become aberrant and depressive. 
An established example is the response to vaccination (e.g. positive reinforcing immunity) versus 
the response to primary exposure to high toxicant levels (e.g. overwhelmed immunity and shock) 
(Figure 3.6A). 
Figures 3.4 and 3.5 reveal similar as well as distinct functional patterns associated with 
each of the most highly altered miRNAs. mir-2216* was not predicted to regulate any of the 
enriched processes, while mir-47St was the most pleiotropic miRNA. The remaining miRNAs 
 66 
 
were involved in one or more of the enriched pathways. Also, mir-80 was the only miRNA 
whose expression was differentially altered in response to the lower nicotine dose. However, 
twelve other miRNAs were dramatically affected in response to the higher nicotine 
concentration. Eight of them, namely mir-90, mir-38, mir-2220, mir-785, mir-241, mir-255, mir-
80, and mir-47St co-regulate common processes (e.g. transcription). Presumably, the additive 
effect of eight miRNAs is associated with a more robust phenotype. For example, nicotine alters 
the expression levels of acetylcholine receptors. A small increase or decrease in the cell surface 
receptors might be associated with increased receptivity or saturation and therefore a resulting 
excitation of the downstream pathways such as muscle contraction. Conversely, a dramatic 
upregulation or depression in the transcription of the receptors might lead to a permanent 
transduction or an inhibition of the signal. Such is consistent with previously reported studies 
where nicotine increased muscle contraction, egg laying and hindered male reproduction 
behavior at lower levels, finally leading to muscle paralysis at high concentrations (Feng, et al. 
2006; Sobkowiak, et al. 2011; Waggoner, et al. 2000).  
Interestingly, mir-80 belongs to the mir-58 family that includes mir-58, mir-80, mir-81, 
mir-82, and mir-1834 (Alvarez-Saavedra and Horvitz 2010).  The deletion of mir-80 was 
associated with healthy ageing, decrease in body and brood size (Vora 2011). Therefore, one can 
anticipate a generally reversed phenotype in L4 worms exposed to nicotine during their larval 
stages. Nicotine can therefore have a negative effect on lifespan, while it alters the body size and 
reproduction and such can be partially mediated by nicotine-induced mir-80 upregulation.  
Nicotine induces addiction 
A more holistic approach takes into consideration all miRNAs as a system. A slight 
trigger can be inductive to certain pathways, while strong stimuli can render the system 
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hyperactive and eventually problematic. However, induction is not necessarily positive as it may 
initiate or promote the activation of pathological pathways (e.g. drug dependence). Thus, it is 
intriguing to understand nicotine-linked phenotypes, particularly at the lower doses. Indeed, 
nicotine did cause an increase in locomotion and egg laying in C. elegans at 20µM. However, 
nicotine is also very addictive. Addiction is defined as a maladaptive form of neuroplasticity. 
The latter refers to the ability to adapt and respond to fluctuations in the environment. It 
promotes seeking and recognizing effectors important for survival while avoiding dangerous 
signals. However, long periods of stress (e.g. drugs of abuse) cause structural (e.g. alterations in 
receptors) as well as molecular changes (Nestler 2001; Robinson and Kolb 2004). 
Gene expression is regulated by a variety of players such as transcriptional factors. The 
Fos family of transcription factors is important for the induction and maintenance of long-term 
plasticity and is induced and stabilized in response to wide range of acute stimuli, while it is 
desensitized after chronic treatment (e.g. drugs of abuse). Histone modifications have been 
reported to have a role in promoting the transient versus permanent transcriptional states for fos-
1(Maze and Nestler 2011).   
Fos-1 has a role in dendrite development. In drosophila single neuron model, fos-1 
related alterations was restricted to only a small time window during development and was not 
recapitulated when introduced during adulthood (Vonhoff, et al. 2013). Interestingly, in our 
study, fos-1 was one of the genes predicted to be highly targeted (≥4 miRNAs) and might thus 
mediate an “addiction-like” behavior in C. elegans larvae. As a conclusion, we hypothesized a 
model that might explain nicotine addiction phenotype (Figure 3.6B). Chronic nicotine treatment 
limited to the post-embryonic stages alters miRNA expression levels (e.g. mir-47*, mir-241, mir-
255, and mir-785) which negatively regulate fos-1 expression. The downstream effects would be 
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remodeling of dendrite branching and disruption in axon guidance and other neurotransmitters 
and receptors. As conclusion, the effect of miRNAs on fos-1, complemented by epigenetic 
modifications, may mediate nicotine addiction initiated during post-embryonic stages. 
Finally, the highest shift in nicotine-induced fold changes was observed for mir-2220. 
However, mir-2220 was not predicted to regulate any of the 13, highly targeted genes. Perhaps,  
when miRNAs act redundantly, the additive increase in their expression levels fulfills the 
finetuning of their targets in response to the environment. On the contrary, when a miRNA 
targets more specific genes, a more dramatic shift in its expression is observed to accomodomate 
and respond to the new condition.  
We limited our analysis based on criteria described above in an attempt to buffer possible 
signal from noise. Our data showed that nicotine altered the profiles of several miRNAs 
predicted to have pleiotropic roles. Therefore, its impact would be expected to be extensive and 
involves major pathways. miRNAs are known to co-target many genes. Researchers interpreted 
such a phenomenon as a mean to fine tune gene expression and provide robustness against 
environmental perturbations. Rather than completely switching gene expression, miRNAs’ 
impact is cumulative. Together they fine tune and stabilize regulatory networks to establish 
relatively normal physiologies in response to fluctuating environments (Li, et al. 2009). 
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 Low High 
 P value Fold change ± SE P value Fold change ± SE 
*Lin4 0.761 0.12 ± 0.34 0.002 -0.56 ± 0.08 
*miR1018 0.375 0.33 ± 0.29 0.013 0.54 ± 0.13 
*miR1022 0.491 0.67 ± 0.80 0.040 0.58 ± 0.12 
*miR1817 0.627 0.10 ± 0.18 0.038 0.70 ± 0.23 
*miR1820 0.861 -0.07 ± 0.36 0.000 -0.49 ± 0.03 
*miR1821 0.669 -0.15 ± 0.31 0.030 -0.58 ± 0.10 
*miR1829b 0.839 -0.13 ± 0.57 0.037 1.10 ± 0.36 
*miR1833 0.723 0.11 ± 0.26 0.018 0.82 ± 0.21 
*miR2209a 0.796 -0.08 ± 0.26 0.000 0.47 ± 0.02 
*miR2210 0.207 0.57 ± 0.31 0.030 1.55 ± 0.28 
*miR2215 0.772 0.09 ± 0.28 0.035 0.79 ± 0.15 
*miR2216St 0.235 1.05 ± 0.62 0.034 1.32 ± 0.25 
*miR2218aSt 0.814 0.07 ± 0.28 0.024 0.74 ± 0.12 
*miR2218bSt 0.405 0.52 ± 0.56 0.036 0.91 ± 0.29 
*miR2220 0.465 0.52 ± 0.58 0.034 3.44 ± 0.65 
βmiR230St 0.019 -0.49 ± 0.07 0.600 0.27 ± 0.44 
*miR235 0.935 0.03 ± 0.28 0.043 -0.52 ± 0.11 
*miR241 0.753 0.16 ± 0.45 0.017 1.02 ± 0.14 
*miR242 0.469 0.47 ± 0.59 0.035 0.99 ± 0.19 
*miR243 0.371 -0.09 ± 0.08 0.025 0.64 ± 0.10 
*miR255 0.981 -0.01 ± 0.59 0.003 1.19 ± 0.14 
*miR258 0.351 -0.23 ± 0.19 0.021 0.47 ± 0.07 
*miR259 0.492 -0.14 ± 0.18 0.002 -0.49 ± 0.07 
*miR358St 0.316 -0.26 ± 0.23 0.023 -0.49 ± 0.08 
*miR38 0.359 0.23 ± 0.22 0.004 1.20 ± 0.08 
*miR47St 0.164 0.74 ± 0.34 0.027 1.34 ± 0.22 
*miR49 0.984 -0.01 ± 0.45 0.019 1.30 ± 0.18 
*miR54 0.712 0.07 ± 0.16 0.023 0.89 ± 0.14 
*miR55 0.081 -0.36 ± 0.11 0.003 -0.52 ± 0.03 
*miR58 0.623 0.19 ± 0.35 0.014 -0.67 ± 0.08 
*miR76 0.885 -0.06 ± 0.36 0.029 0.59 ± 0.10 
*miR785 0.220 0.47 ± 0.30 0.003 1.08 ± 0.16 
*miR789 0.076 0.64 ± 0.19 0.014 0.49 ± 0.12 
βmiR79 0.022 0.86 ± 0.20 0.392 -0.11 ± 0.10 
*miR794 0.617 0.19 ± 0.33 0.000 0.56 ± 0.02 
*miR798 0.970 -0.01 ± 0.26 0.032 0.89 ± 0.16 
*miR799 0.512 -0.15 ± 0.19 0.014 0.46 ± 0.05 
β*miR80 0.045 1.01 ± 0.30 0.011 0.86 ± 0.09 
*miR800 0.755 0.11 ± 0.31 0.016 0.60 ± 0.15 
*miR90 0.251 0.33 ± 0.23 0.045 1.69 ± 0.37 
Table 3.2: A summary of differential miRNA-fold change (±SE) in response to low (20µM) and high (20mM) nicotine 
treatments in L4 C. elegans (N2). (* and β) denote P<0.05 in response to high and low nicotine doses, respectively. 
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Table 3.3: A list of proposed genes that are targeted by ≥4 miRNAs. Gene descriptions were summarized from 
DAVID and WormBase (Yook, et al. 2012) . 
 
Gene 
symbol 
Description Function 
ain-2  ain-1 paralogue no obvious function in mass RNAi assays. Belongs to GW182 
protein family.  
B0336.3  body morphogenesis, regulation of growth, regulation of growth 
rate, positive regulation of growth rate, positive regulation of 
growth 
C48A7.2  reproductive developmental process, ion transport, phosphate 
transport, anion transport, intracellular protein transport, sex 
differentiation, protein localization, embryonic development 
ending in birth or egg hatching, protein transport, inorganic 
anion transport, vesicle-mediated transport, cellular protein 
localization, negative regulation of vulval development, 
regulation of vulval development, hermaphrodite genitalia 
development, establishment of protein localization, intracellular 
transport, regulation of post-embryonic development, negative 
regulation of post-embryonic development, genitalia 
development, cellular macromolecule localization 
ceh-44 Homeobox transcription, regulation of transcription, DNA-dependent, intra-
Golgi vesicle-mediated transport, vesicle-mediated 
transport,regulation of transcription, intracellular transport, 
Golgi vesicle transport, regulation of RNA metabolic process 
F10D2.10  Unknown function,  lipase putative 
F40F11.2  embryonic development ending in birth or egg hatching, 
oxidation reduction 
fos-1  FOS (B-Zip 
transcription 
factor) 
homolog 
cell fate specification, morphogenesis of an epithelium, 
reproductive developmental process, regulation of transcription, 
DNA-dependent, regulation of transcription from RNA 
polymerase II promoter, sex differentiation, positive regulation 
of biosynthetic process, positive regulation of macromolecule 
biosynthetic process, positive regulation of macromolecule 
metabolic process, positive regulation of gene expression, 
positive regulation of cellular biosynthetic process, regulation of 
gene-specific transcription, hermaphrodite genitalia 
development, positive regulation of gene-specific transcription, 
cell fate commitment, regulation of transcription, positive 
regulation of transcription, DNA-dependent, positive regulation 
of nucleobase, nucleoside, nucleotide and nucleic acid metabolic 
process, positive regulation of transcription, positive regulation 
of transcription from RNA polymerase II promoter, tissue 
morphogenesis, genitalia development, positive regulation of 
nitrogen compound metabolic process, regulation of RNA 
metabolic process, positive regulation of RNA metabolic 
process, regulation of syncytium formation by plasma membrane 
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fusion, epithelium development 
let-75 LEThal nematode larval development, larval development, muscle 
system process, muscle contraction, post-embryonic 
development, embryonic development ending in birth or egg 
hatching, growth 
ptc-1 PaTChed 
family 
M phase of mitotic cell cycle, mitotic cell cycle, M phase, 
nuclear division, nematode larval development, larval 
development, cell cycle, mitosis, behavior, post-embryonic 
development, embryonic development ending in birth or egg 
hatching, molting cycle, protein-based cuticle, oviposition, 
molting cycle, collagen and cuticulin-based cuticle, reproductive 
behavior, cell cycle process, cell cycle phase, multicellular 
organism reproduction, reproductive behavior in a multicellular 
organism, growth, molting cycle, organelle fission, reproductive 
process in a multicellular organism, cell division 
sax-3 Sensory AXon 
guidance 
regulation of growth, regulation of growth rate, positive 
regulation of growth rate, positive regulation of growth 
sem-4 SEx Muscle 
abnormal 
behavior, oviposition, reproductive behavior, multicellular 
organism reproduction, reproductive behavior in a multicellular 
organism, regulation of growth, regulation of growth rate, 
positive regulation of growth rate, positive regulation of growth, 
reproductive process in a multicellular organism 
tag-97 Temporarily 
Assigned Gene 
name 
regulation of transcription, DNA-dependent, regulation of 
transcription, regulation of RNA metabolic process 
tsp-14 TetraSPanin 
family 
defense mechanisms 
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Figure 3.1 Analyzing nicotine-induced alterations in miRNA expression levels through heat map and hierarchical clustering. (A) Centroid graph showing the 
stability of the total mean fold change of the 231 miRNAs.(B) Expression graphs for 231 miRNAs (top) and 40 miRNAs that showed differential expression in 
response to nicotine (bottom). Each line represents one the expression of one miRNA across the treatment groups.  (C) Heat map showing expression profiles of 
231 miRNAs. (D) Heat map of 40  miRNAs considered to be differentially regulated. Hierarchical clustering was performed with Euclidean distance based on 
single linkage for each of the miRNAs among all the treatment groups. Note: from left to right, three biological replicates of each: 20µM (L), and 20mM (H)  
treatment groups. Each cell represents a MFC compared to control (Mean Fold Change: 2
(∆∆CT) 
-1). In the figures, color red, green, and black represnet up-
regualtion, down-regulation and no change, respectively. Heat maps and clustering were done using Mev software.
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Figure 3.2: Nicotine treatment was associated with altered expression of 40 miRNAs in L4 C. elegans (N2). (A) 
miRNA expression is represented as fold change 2
∆∆Ct. (∆∆Ct=∆Ctcontrol-∆Cttreatment). miRNAs whose expression 
changes with a P<0.05 and fold change ≥0.5 and ≤ -0.5, respectively.  (*) and (β) denote P<0.05 for the high and 
low treatment groups, respectively in comparison to control.  B) Venn diagram showing the number of miRNAs 
whose expression was altered in response to low, high, or both nicotine concentrations. 
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Figure 3.3: Directed acyclic graph (DAG) performed by GOrilla. It shows the relationships among the enriched pathways targeted by miRNAs altered in 
response to nicotine treatment. Colors represent P-values. From white to dark orange, P-values range from >10^-3 to <10^-9.  
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Figure 3.4: Nicotine-induced miRNAs differentially regulate five major biological pathways. (A) summary of 
pathways enriched by GOrilla based on the predicted target genes for the 13 most highly altered miRNAs 
(MCF>1). The data labels at the edge of each bar represent the p-values calculated for each enrichment value. 
(B) Functional distribution of the 13 most highly altered miRNAs in response to nicotine. Each miRNA was 
associated with none, one or more, or all of the enriched pathways. Next to each miRNA name ( ) is the number 
of targets predicted for each miRNA by mirSOM.  
A 
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Figure 3.5: A miRNA-target network showing the pleiotropic and redundant nature of all of the highly altered 
miRNAs in response to nicotine treatment in L4 C. elegans (N2). (A) The network included 13 miRNAs and 
2877 predicted targets. (B) Only genes commonly targeted by at least 4 of the differentially altered miRNAs 
were used. Thus 13 miRNAs and 13 gene targets were used to construct this network. (C) Nicotine-butterfly 
effect shows possible matches among each of the highly altered miRNAs with the five enriched functional hubs 
(GOrilla). Networks were constructed by Cytoscape. Each red dot represents a match between one miRNA and 
one hub.  
A B 
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Figure 3.6: A miRNA system mediates “regulatory hormesis” and addiction. (A) As nicotine concentration increases, the 
number of affected miRNAs increases. The latter is associated with a biphasic behavioral and physiological phenotype. (B) A 
proposed model that explains nicotine addiction as a function of miRNAs’s regulation of fos-1 and maintenance of effect by 
epigenetic factors. 
  
Chapter Four: Determination of reliable reference genes for multi-
generational qRT-PCR gene expression analysis on C. elegans exposed to 
nicotine drug of abuse. 
 
Abstract 
Recently, an increasing number of studies have been focused on multi-generational 
toxicogenomics impacts. Such studies rely on behavioral as well as genetic and epigenetic 
analyses using a range of biotechniques. Of these technologies, qRT-PCR is considered to be a 
mature “discovery and validation tool”. Nevertheless, the interpretation of the resulting gene 
expression necessitates the establishment of reliable internal controls for normalization. No study 
has been performed to identify reliable reference genes in multi-generational settings. In this 
study, we exposed the model organism C. elegans to nicotine in the F0 generation, and 
investigated the relative stabilities of 16 housekeeping genes in L4 larvae across three 
generations (F0, F1, and F2). Based on results from five statistical approaches (geNorm, ∆Ct 
method, NormFinder, BestKeeper, and ReFinder), TBA-1 and CDC-42 were the two most stable 
reference genes for performing reliable gene expression normalization and interpretation of the 
multigenerational impact of nicotine exposure.  
Key words: qRT-PCR, reference genes, multi-generational, C. elegans, nicotine, drugs of abuse 
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Introduction 
Transcriptome studies have revolutionized molecular biology. Despite the increasing 
popularity of some advanced “discovery” technologies such as next generation sequencing 
(NGS) (e.g. RNA-seq), those high-throughput, sensitive technologies are still at a juvenile stage. 
Major drawbacks are attributed to the absence of standardized data analyses approaches  and 
inability to distinguish between signal and noise (Pertea 2012).  Inconsistencies in the data are 
further corrected and validated via more established technologies such as qRT-PCR that has been 
serving as a valuable mature tool for the validation of various transcriptome-related micro-arrays 
and NGS (Git, et al. 2010). 
qRT-PCR is a mature biotechnique with both advantages and limitations. Efforts to 
correct for biases and variations caused by experimental errors and data handling have long been 
investigated and reported (Lefever, et al. 2009). In qRT-PCR, such can be accounted for by 
many factors, including the total RNA quantity and integrity, enzymatic efficiencies, total 
transcriptional status of cells or organisms as a whole, as well as pipetting errors (Ginzinger 
2002). To correct some of these false positive results, genes of interest are normalized to genes 
(i.e. reference genes) that ideally have almost constant expression levels in the tested 
environmental conditions. The choice of a reference gene is not trivial. It has been concluded 
that there is no “universally suitable” reference gene. With this in mind, control genes should be 
selected based on the nature of the investigation and are expected to be resistant to the induced 
perturbations and modifications (Hruz, et al. 2011). 
Many studies have been done to investigate the mechanism of action of nicotine in 
different organisms (e.g. cell culture, rats, mice, drosophila, zebrafish, C. elegans) (Matta, et al. 
2007). Of the 4000 chemicals in tobacco smoking, nicotine has received a lot of attention due to 
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its addictive and toxic properties (CDC 1988; CDC 2010). Unfortunately, addiction is a 
universally notorious disease that affects millions worldwide. Despite concentrated efforts to 
limit nicotine exposure, the rate of tobacco smoking remains high in many developing countries 
and particularly among youth and children (WHO 2012). The obscurity of the molecular 
mechanisms of maladaptive neuroplasticity like addiction, especially on children, necessitates 
further in depth research to understand the extent of physiological disruptions. Our ongoing 
study implies the extension of addictive behavioral and molecular biomarkers across generations. 
Such an association is expected to trigger further replications and more in depth experiments 
involving protein coding as well as non-coding genes. For reasons described below, we 
employed C. elegans as our model organism to investigate the systemic mechanism of action of 
nicotine.  
C. elegans is one of the major model organisms (Brenner 1974) which can be easily and 
economically maintained. Research on C. elegans is free of ethical concern and has contributed 
to advances in the biomedical fields.  Up to 80% of its genome is homologous to that of humans 
(Beitel, et al. 1990) and is characterized by fewer genetic redundancies in coding and non-coding 
sequences (Kazazian 2004; Kirienko, et al. 2010). So far, extensive toxicogenomics research has 
been conducted on C. elegans in specific developmental stages and in response to different 
treatments (Karp, et al. 2011; Lant and Storey 2010; Pincus, et al. 2011; Viñuela, et al. 2010). 
However, correct interpretations and extrapolations on the genetic level necessitate reliable and 
sensitive control reference genes. With transgenerational nicotine addiction being the main focus 
of our research, our objective was concerned with finding suitable gene candidates to correct for 
any false-positive results and conclusions.    
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In this study, we compiled a list of reference gene candidates from previous publications 
that included both protein coding and RNA genes. We were interested in investigating the 
relative stabilities of the selected genes in response to nicotine across three generations. In our 
experiment, wild type L1 worms (N2) were distributed into three treatment groups: 0µM 
(control), 20µM and 20mM nicotine NGM plates. Worms were exposed to nicotine until early 
L4 stage (~30 hours). Exposure was restricted to the F0 generation, but we continued sampling 
L4 worms in both F1 and F2 generations. Among the sixteen selected genes, we aimed to 
determine the most reliable gene candidate(s) that can be used in nicotine related 
transgenerational molecular studies. To accomplish our objective, we used four of the most 
popular reference gene analysis software tools: geNorm, NormFinder, comparative ∆Ct method, 
and BestKeeper. Taking all into consideration, the most stable gene(s) candidate was (were) 
determined by an overall comprehensive ranking approach (Xie, et al. 2012).  
As a summary, recent evidence shows that environmental exposure can cause 
multigenerational impacts on animal growth and development and even some diseases 
(Contreras, et al. 2012; Tominaga, et al. 2003; Yu, et al. 2012). On the other hand, several other 
reports have demonstrated that chemicals may induce transgenerational alterations in gene 
expression (Ashe, et al. 2012; Braunschweig, et al. 2012; Manikkam, et al. 2012). However, no 
study has been performed to examine the effect of any chemical on housekeeping genes and thus 
no reliable reference genes exist for mutigenerational investigations. In this study, we employed 
C. elegans as an animal model system to evaluate and identify the most reliable reference genes 
for future mutigenerational toxico-genomics approaches and gene expression analyses related to 
nicotine addiction.  
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Material and methods 
Chemicals and C. elegans strains 
Nicotine was purchased from Acros Organics (New Jersey, USA). 1 M and 0.001 M 
stocks were prepared by diluting nicotine in phosphate buffer. From the two stock solutions, 
nicotine was then added into the NGM medium, after the addition of cholesterol, CaCl2, MgSO4, 
and KH2PO4, to give final concentrations of 20 µM and 20 mM, respectively.  
C. elegans hermaphrodite N2 Bristol wild type was used. Worms were constantly 
transferred via chunking method to a new NGM plate freshly seeded with OP50.  
Egg synchronization was done via bleaching (Sulston and Hodgkin 1988a). Briefly, M9 
buffer was used to wash adult gravid worms off the plate into 15 ml Falcon tubes. Then the 
Falcon tube was centrifuged at 2000 rpm for 2 minutes, respectively. After discarding the 
supernatant, the wash was repeated. Then, 5 ml of synchronization solution (70% dH2O, 10% 
NaOH, and 20% bleach) was added. The tubes were vigorously shaken (or vortexed) for a 
maximum of 5 minutes until the adult worms burst leaving the eggs dispersed in solution. The 
tubes were then spun at 2000 for 2 minutes. The supernatant was removed and three to four 5-ml 
M9 washes followed leaving the last wash without centrifugation. The tubes with the suspended 
eggs were placed on a shaker in the 20
o
C incubator for 14-18 hours maximum (to avoid 
starvation). After hatching, the L1 larvae were pooled and randomly transferred to the different 
treatment groups.  
 The three treatment groups included the control group, the 20µM and 20mM nicotine 
treatment groups. L1 larvae of the F0 generation were incubated at 20
o
C on seeded control and 
treatment plates for about 31 hours until end of L3-beginning of L4. From each plate, worms 
were unequally harvested off the plates into two eppendorf tubes. The one with the larger pellet 
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was intermittently centrifuged two times at 2000 rpm then 3000 rpm to separate the worms from 
bacteria and debris. Consequentially, the pellet was flash frozen in liquid nitrogen, and then 
stored at -80
o
C until molecular analysis. As for the tube with the smaller pellet, the L4 worms 
were then transferred into OP50-seeded NGM plates, left to dry, then sealed and placed back in 
the 20
o
C incubator to grow until egg-laying peaked (around second day of adulthood). Adults 
were then collected for synchronization to gather the eggs for the subsequent generation. The 
whole procedure was repeated until L4 of the F2 generation was reached. 
RNA extraction and qRT-PCR  
Total RNA extraction was performed according to protocol using mirVana™ miRNA 
Isolation Kit (Ambion, Austin, TX). Briefly, the sample was denatured using a lysis buffer. RNA 
was then separated from DNA and other proteins via acid-phenol extraction. Then, ethanol was 
added to the sample followed by passing through a glass-filter. Several washes preceded the 
elution of the RNA with low ionic strength solution. 
RNA quantification and evaluation were done using the NanoDrop ND-1000 Micro-
Volume UV/Vis Spectrophotometer (NanoDrop Technologies, Wilmington, DE) and  were 
based on the concentration (ng/µL) and absorbance ratios of 260/280 and 260/230.  
Reverse transcription was performed using TaqMan microRNA Reverse Transcription kit 
from Applied Biosystems (Foster City, CA) to reverse-transcribe RNA to cDNA for both protein 
coding genes and small RNAs . The poly-T was used for protein-coding genes and specific 
primers were used for small RNAs. For each reaction, the final reaction volume was 15 µL and 
included 1000ng of total RNAs, 0.19µL RNase inhibitor (20U/µL), 0.15µL of 100mM dNTPs, 
1.5µL of reverse transcription buffer (10X), 2µL of primer mix, and 1µL of reverse transcriptase 
(50U/µL). The samples were then run via thermal cycler using the program: 16
o
C for 30 min 
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followed by 42
o
C for 30 min, 85
o
C for 5 min and were finally held at 4
o
C. The samples were 
diluted in 80µL DNase/RNase-free water for subsequent qRT-PCR. 
The expression levels of selected genes were analyzed after performing qRT-PCR on 96-
well-plate using the 7300 Real-Time PCR System (Applied Biosystem) using the SYBR Green 
PCR master mix from SuperArray Bioscience Corp. (Frederick, MD). Specific reverse and 
forward primers were used for each tested gene (Table 4.1). Briefly, each well carried a 20µL 
reaction resulting from the combination of 7µL DNase/RNase free water, 10µL SYBR Green 
master mix, 1µL cDNA, 2µL primer mix. A minimum of three biological replicates with two 
technical replicates were run. The qRT-PCR program was started at 95
o
C for 10 min for enzyme 
activation followed by denaturation for 15 sec at 95
o
C and an annealing/extension step for 60 sec 
at 60
o
C. The latter 2 steps were repeated for 40 cycles. 
Primer specificity and efficiency have been previously calculated. Moreover, descriptive 
statistics (i.e. mean, SD) were calculated via SPSS for the raw Ct values of each gene candidate. 
Boxplot graphs were done via SPSS20 (Figure 4.1; Table 4.2).  
Determination of gene stability 
Five different statistical approaches (geNorm, ∆Ct method, NormFinder, BestKeeper, and 
ReFinder) were employed to determine the stability of each tested reference gene candidate.  
The geNorm (Vandesompele, et al. 2002) applet allows the determination of the most 
stable reference gene(s) based on pairwise comparisons between each gene with all other 
candidates. The variation in expression levels of each gene is calculated as the geometric mean 
of the standard deviation relative to all other genes. Such a stability index is described as the ‘M-
value’. Ranking is achieved after sequential elimination of most variable gene, followed by 
recalculation of the ‘M-value’. Finally, genes with the lowest ‘M-value’ will be ranked with 
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highest stability in comparison with the other tested genes. Conceptually, geNorm assumes that 
an ideal-gene pair will have the least variation in expression in all samples regardless of 
experimental conditions. GeNorm goes beyond that to estimate the minimal n (e.g. number of 
genes) needed to perform reliable normalization. This is based on pairwise variation [Vn/Vn+1] 
calculated for each gene pair normalization factors [NFn, NFn+1]. Through this approach, the 
need for the inclusion of an additional reference gene would be reflected by a high variation (i.e. 
>0.15 established cutoff value), and vice versa.   
To prepare the input for geNorm, relative quantification from raw Ct values among all 
samples was done for each gene. Briefly, the smallest Ct value was determined for each gene 
among all samples. Then, this value was subtracted from all the other Ct values related to this 
gene. Therefore, the minimal value would be zero. Then, each value is transformed using the 
formula: 2^
(Ctoriginical-Ctmin)
. The resulting converted data were used as input for geNorm with the 
names of the genes and samples in the first row and column, respectively. Together, they were 
saved in the provided input directory. After loading the input file into geNorm, the analysis was 
run and two charts were automatically generated as shown in Figure 4.2. 
The comparative delta Ct method (Silver, et al. 2006) is a relatively similar approach that 
depends on pairwise comparisons between genes. This method can be easily done on an excel 
spreadsheet without the help of a designed program. In addition, its development facilitated gene 
expression normalization for experiments with non-ideal sample sizes and purity. Simply, a set 
of comparisons is performed where each gene is compared against all other gene candidates. The 
∆Ct was calculated for every gene pair in each sample across all treatment groups. For every 
gene pair, the mean ∆Ct and SD were calculated. A high SD reflects that one or both genes are 
not stable. Then, an overall average SD was calculated for every gene being compared against all 
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others (i.e. gene pair set). Including more genes into the comparison will allow for the selection 
of the one with the least variability. Thus, the gene with the least SD will be the top-ranked 
candidate for normalization. Calculations for the comparative ∆Ct method were done using excel 
spreadsheet as described above. Boxplots were generated via SPSS20. For each gene set, 
different colors represent different ‘gene pairs’ as shown in Figure 4.3 and Table 4.4. 
Whereas pairwise comparison approaches focus on intra-group variation with less, if any, 
consideration on the inter-group variation, NormFinder (Andersen, et al. 2004) ranks gene 
stability based on minimal variation of samples not only among all treatment groups, but also 
within each group. NormFinder prevents the exclusion of stable genes with different expression 
levels that would otherwise be ranked as one of the least stable through pairwise comparison. In 
addition false positive results caused by co-regulated genes with similar expression patterns 
would be avoided. Through NormFinder, a top-ranked gene would introduce the least systemic 
error when used for normalization.  
Another excel-based applet is BestKeeper (Pfaffl, et al. 2004) that allows the analysis of 
10 reference gene candidates as well as target genes for many samples. For that, we excluded the 
6 least stable genes (AMA-1, RBD-1, PMP-3, ACT-2, Ce234.1, and U18) based on geNorm, 
NormFinder, and delta Ct method. Its ranking is a result of a stepwise process that starts with the 
exclusion of genes with expressions having an SD>1. To analyze the relationships of candidate 
genes with one another, a series of pairwise comparisons between each pair is calculated as 
Pearson’s correlation coefficient [r]. Then, based on the most highly correlated genes, the 
geometric mean of the Ct values is used to calculate an index. After a pairwise-correlation 
analysis of each candidate gene with BestKeeper index, genes with the highest statistically 
significant correlation coefficient represent the most stable genes, and vice versa. 
 91 
 
Results 
Descriptive statistics for expression levels of candidate reference genes 
Figure 4.1 demonstrates the expression levels of each reference gene candidate. The 
expression levels were calculated from the original Ct values for all samples belonging to three 
nicotine treatment groups (control, 20µM, and 20mM) across three generations (F0, F1 and F2). 
Taking the median Ct values into consideration, the three genes that had the least median Ct 
values were 18s rRNA, ACT-2, and TBA-1 with Ctmedian of 14.16, 20.39, and 20.65, respectively. 
On the other hand, the ones with the highest Ct values were RBD-1, ARP-6, and U18 with 
Ctmedian values of 23.79, 24.77, and 25.00, respectively. However, looking at the variations in the 
Ct values among treatment groups and generations, it appears that the least variable genes were 
18s RNA, U6 and PMP-3 with SD values of 0.49, 0.61, and 0.63, respectively. Conversely, the 
three most variable genes were CSQ-1, ACT-2, and U18 with SD values of 1.28, 1.29, and 1.48, 
respectively. Of the 16 tested genes, U18 would not be a reliable reference gene as it had the 
lowest and the most variable expression levels among all the samples. Also, ACT-2 would not be 
a reliable reference gene because its expression level varied greatly among different treatments 
and across different generations.  
Generally speaking, a good reference gene should have an expression level that is in the 
similar range relative to the targeted genes (Cappelli, et al. 2008). Although 18S rRNA had a 
relatively stable expression level, it might not be considered as a suitable reference gene because 
its expression is too high. Thus, simple statistical criteria based solely on numerical values may 
mask genomic context.  More measures should be taken into account when selecting the top 
reference gene(s) from the candidate list for particular experimental settings. With this in mind, 
we took advantage of five previously established statistical approaches (geNorm, NormFinder, 
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BestKeeper, comparative ∆Ct method, and comprehensive ranking) to evaluate each individual 
reference gene candidate. This facilitated the final determination of more reliable reference genes 
for qRT-PCR normalization in C. elegans across three generations after parental nicotine 
exposure.  
Reference gene ranking based on geNorm 
GeNorm ranks the reference genes based on the stability value (M value). The lower the 
M-value, the more stable the gene. Figure 4.2 clearly shows that CDC-42 and Y45F10D.4 were 
the most stable genes among the gene candidates with the least M-value of 0.198. ARP-6 
(0.223), EIF3.C (0.271), and TBA-1 (0.292) had close M-values. The least stable genes were 
RBD-1 (0.542), U18 (0.603), AMA-1(0.679), Ce234.1 (0.741) and PMP-3 (0.794).  The rank of 
Y45F10D.4 was consistent with previous studies using IIS-mutants, dauers and L3 worms 
(Hoogewijs, et al. 2008) as well as L4 worms treated with copper oxide (Zhang, et al. 2012). 
However, a drastic change in PMP-3 stability index was evident as it was ranked as the least 
stable gene in our experimental settings. The rank of CDC-42 was consistent with one study 
(Hoogewijs, et al. 2008), but not the other (Zhang, et al. 2012). 
In order to examine the minimal number of genes required for reliable normalization, the 
V-value for all the gene pairs was calculated and was less than 0.15 (the default cutoff) (Figure 
4.2). This suggests that the introduction of a new gene was not associated with high variation in 
the relative expression levels. Thus, taking both indices (M and V-values) together, it can be 
inferred that CDC-42 and Y45F10D.4 are enough for a reliable normalization (Figure 4.2).  
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Reference gene ranking based on NormFinder 
Based on NormFinder, TBA-1(0.18), EIF3.C (0.22), ARP-6 (0.27), CDC-42 (0.29), and 
MDH-2 (0.31) show the lowest stability values (Table 4.5) and may serve as the top five reliable 
reference genes. This rank was similar to that of geNorm, although the exact order was not 
identical. The inclusion of TBA-1, EIF3.C, ARP-6, and CDC-42 among the top-ranked genes 
was common to both analyses. Previous reports using the same methods placed TBA-1 and 
EIF3.C among the top five stable genes (Zhang, et al. 2012). As for the least stable genes, our 
results show that ACT-2 (0.71), U18 (0.93), AMA-1 (0.95), Ce234.1 (1.00), and PMP-3(1.04) 
were ranked last. Interestingly, the lowest four genes were ordered exactly like geNorm as 
mentioned above.  AMA-1 was also found among the least stable with other experimental 
conditions, but this was not the case for PMP-3 (Zhang, et al. 2012).  
Reference gene ranking based on comparative ∆Ct method  
Comparative ∆Ct method ranked TBA-1(0.595), CDC-42 (0.606), EIF3.C (0.607), ARP-
6 (0.614), and Y45F10D.4 (0.631) as the most stable reference genes among the 16 candidate 
genes (Table 4.5). Although the order was slightly different, it was similar to the top five genes 
ranked in geNorm and top four genes ranked in NormFinder. On the other hand, the least stable 
genes were ACT-2 (0.852), U18 (1.064), AMA-1(1.098), Ce-234.1(1.131), PMP-3(1.162) 
(Figure 4.3; Table 4.4). Most were consistent with results from NormFinder and  geNorm. 
Despite the fact that this method depends on a simpler statistical methodology, it agreed with 
other sophisticated approaches. Comparing our results with studies that used the ∆Ct method, 
TBA-1, EIF-3 and Y45F10D.4 were also among the more stable genes (Zhang, et al. 2012). 
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Also, AMA-1 was of the least reliable genes for normalization, while ARP-6, and CDC-42 were 
among the least stable in their study (Zhang, et al. 2012).  
Reference gene ranking based on BestKeeper 
BestKeeper calculations depend on two criteria to deduce suitable reference genes. The 
initial analysis was based on the SD values and ranked 18s rRNA (0.40), U6 (0.49), EIF3.C 
(0.69), TBA-1(0.70), ARP-6 (0.79) with the least variable expression levels (Table 4.3). The 
results obtained from BestKeeper did not completely agree with those obtained from geNorm, 
NormFinder, and ∆Ct method. Despite its relatively stable expression, 18s rRNA had a much 
higher expression level compared to other genes and it was therefore not a good candidate. 
However, when considering the index based on pairwise correlation calculations (i.e. r-
coefficients), Y45F10D.4 (0.989), F35G12.2 (0.986), TBA-1(0.980), CDC-42 (0.978), and CSQ-
1(0.971) were ranked as the best (Table 4.3).  Taking both criteria into consideration, 
Y45F10D.4 and F35G12.2 had the highest (r-value); however, together with CSQ-1, they had the 
most variable expression levels among the treatment groups and generations (SDY45F10D.4=0.92, 
SDF35G12.2=0.97, SDCSQ-1=1.11). As a conclusion, the expression levels of TBA-1(SD=0.70) and 
CDC-42 (SD=0.83) were relatively stable and highly correlated with the BestKeeper index at 
P=0.001. This result was consistent with results from geNorm and NormFinder. Additionally, 
TBA-1 was also among the five most stable genes ranked by BestKeeper in a previous study on 
L4 worms exposed to nanoparticle treatment (Zhang, et al. 2012).  
Comprehensive ranking 
Taking advantage of the different angles covered by the four different statistical methods, 
we used RefFinder software (Xie, et al. 2012) that accommodates all the logarithms to finally 
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provide an overall comprehensive ranking for the stability of the sixteen gene targets. As shown 
in Table 4.5. TBA-1 (2.51), CDC-42 (2.99), EIF3.C (3.60), ARP-6 (4.24), and Y45F10D.4 (4.36) 
were the most stable housekeeping genes for reference genes in mutigenerational study.  TBA-1 
and Y45F10D.4 were also among the top five enlisted genes (Zhang, et al. 2012). On the other 
hand, the least stable genes were CSQ-1(10.72), AMA-1(10.82), PMP-3(11.31), ACT-2 (11.61), 
and U18 (13.69). The stability index for CSQ-1 and AMA-1 was consistent with previous results 
in response to nanoparticle treatment (Zhang, et al. 2012). The radical shift in PMP-3 remained 
evident in the comprehensive ranking as it was of the least stable genes in our experimental 
settings.  
Discussion 
Previous studies involved in choosing reliable reference genes for qRT-PCR 
normalization have already been conducted in C. elegans (Hoogewijs, et al. 2008; Zhang, et al. 
2012). However, none has evaluated reference genes in multigenerational investigations as a 
function of environmental conditions. Choosing a proper reference gene remains one of the 
golden rules to increase the sensitivity and credibility of data interpretation. Generally, there are 
two types of approaches to tackle the issue: the top-bottom model is not restricted to a set of 
genes and starts with a high-throughput investigation from genome-wide background (e.g. 
microarray). On the other hand, a bottom –top model starts with a handful of genes with 
conserved basic roles and hypothesized to be of relatively constant expression levels (Hruz, et al. 
2011). We were interested in identifying suitable reference genes in C. elegans in response to 
nicotine. Nicotine is one of the major drugs of abuse with high rates of primary and secondary 
exposures. Here, we evaluated the expression levels of sixteen housekeeping genes, including 
four small RNA genes, across multiple generations in response to parental nicotine exposure. 
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We treated C. elegans hermaphrodites (N2) with two nicotine concentrations from L1 to 
the beginning of L4. We collected L4 worms from F0, F1, and F2 generations. All the samples 
from the three treatment groups (control, and nicotine-treated) were used to investigate the 
expression levels of sixteen selected genes. Based on our results, particularly from the 
comprehensive ranking, it appears that TBA-1, CDC-42, EIF3.C, ARP-6 and Y45F10D.4 were 
the most reliable reference genes among the sixteen gene candidates. Based on outputs from the 
different methodologies, all except for BestKeeper considered TBA-1, CDC-42, EIF3.C, ARP-6 
as the most stable genes. When considering results from all methods, including BestKeeper, 
TBA-1 and CDC-42 would be the most reliable reference genes to study the transgenerational 
effect of C. elegans exposed to nicotine. Based on results from geNorm, the combination of two 
reference genes from our list is sufficient for reliable normalization.  Thus, we recommend the 
combination of TBA-1 with any other gene of the top five genes mentioned above. PMP-3, 
AMA-1, and U18 were the least stable and would not be recommended to be used for 
normalization.  
Our results partially agree with previous studies (Hoogewijs, et al. 2008; Zhang, et al. 
2012) where TBA-1, CDC-42 and Y45F10D.4 were the most reliable reference genes. However, 
other genes, such as  PMP-3, were the most reliable reference gene in other reports (Hoogewijs, 
et al. 2008; Zhang, et al. 2012), but were among the least stable genes in our study. This suggests 
that housekeeping genes are differentially affected in a context-dependent manner and that 
assessing potential reference genes should precede expression profile analysis.  
Although reference genes related studies are not novel, the replication of such a concept 
using different treatment conditions and developmental conditions is important for future meta-
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analyses. This allows to test whether an ideal universal reference gene exists or to further 
confirm the concept of condition-specific reference gene selection.  
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Table 4.1: Properties of the sixteen candidate genes. 
Gene 
Symbol 
Locus tag Gene description 
 
Forward primer Reverse primer 
CDC-42 R07G3.1 Cell Division Cycle related AGCCATTCTGGCCGCTCTCG GCAACCGCTTCTCGTTTGGC 
PMP-3 C54G10.3 Peroxisomal Membrane Protein related TGGCCGGATGATGGTGTCGC ACGAACAATGCCAAAGGCCAGC 
EIF-3.C T23D8.4 Eukaryotic Initiation Factor ACACTTGACGAGCCCACCGAC TGCCGCTCGTTCCTTCCTGG 
ARP-6 C08B11.6 Spliceosome-Associated Protein family 
member (sap-49) 
TGGCGGATCGTCGTGCTTCC ACGAGTCTCCTCGTTCGTCCCA 
ACT-2 T04C12.5 ACTin GCGCAAGTACTCCGTCTGGATCG GGGTGTGAAAATCCGTAAGGCAGA 
CSQ-1 F40E10.3 Calsequestrin GCCTTGCGCTAGTGGTTGTGC GCTCTGAGTCGTCCTCTTCCACG 
Y45F10D.4 Y45F10D.4 Putative iron-sulfur cluster assembly 
enzyme 
CGAGAACCCGCGAAATGTCGGA CGGTTGCCAGGGAAGATGAGGC 
TBA-1 F26E4.8 TuBulin, Alpha family member TCAACACTGCCATCGCCGCC TCCAAGCGAGACCAGGCTTCAG 
MDH-2 F20H11.3 Malate DeHydrogenase TGGAGCTGCCGGAGGAATTGG TCAGCGTTCTCAACGGCGGC 
AMA-1 F36A4.7 AMAnitin resistant family member CGGATGGAGGAGCATCGCCG CAGCGGCTGGGGAAGTTGGC 
F35G12.2 F35G12.2 ortholog of mitochondrial NAD+-
isocitrate dehydrogenase. 
ACTGCGTTCATCCGTGCCGC TGCGGTCCTCGAGCTCCTTC 
RBD-1 T23F6.4 RBD(RNA binding domain)protein GGTCAGATTTCCGATGCGTCGCT ACTTGCTCCAGGCTCTCGGC 
U6 CELE_F35C11.9 snRNA involved in mRNA splicing CAGAGAAGATTAGCATGGCCC TTGGAACGCTTCACGAATTTGC 
18s rRNA CELE_F31C3.7 rRNA subunit TTCTTCCATGTCCGGGATAG CCCCACTCTTCTCGAATCAG 
Ce234.1 DQ789547 C/D box snoRNA GGTTACGGTAGCCGAGTCAG GCCATAACTGTTCACCGTCG 
U18 Z75111 snoRNA TGATGATCACAAATCCGTGTTTC GCTCAGCCGGTTTTCTATCG 
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Table 4.2: Overall descriptive statistics of the raw Ct values for each candidate gene among all nicotine treatment groups in L4 C. elegans. 
 N Minimum Maximum Mean SD Median 
CDC42 56 21.16 24.88 23.02 0.97 23.10 
MDH2 56 19.56 23.58 21.52 0.99 21.71 
PMP3 56 21.74 24.31 22.83 0.63 22.72 
AMA1 56 20.25 24.91 22.04 0.76 22.05 
EIF3.C 56 20.14 23.66 21.65 0.83 21.83 
F35G12.2 56 20.48 24.17 22.40 1.11 22.55 
ARP6 56 23.27 26.76 24.77 0.95 24.77 
RBD1 56 22.41 26.10 23.76 0.81 23.79 
ACT2 56 18.43 23.05 20.47 1.29 20.39 
U6 56 19.17 21.89 20.74 0.61 20.88 
CSQ1 56 20.17 24.88 22.59 1.28 22.64 
Ce234.1 56 21.01 23.86 22.09 0.64 22.09 
Y45F10D.4 56 21.12 25.07 23.05 1.08 23.13 
18s rRNA 56 13.01 15.13 14.14 0.49 14.16 
TBA1 56 19.17 22.44 20.70 0.84 20.65 
U18 56 21.17 27.02 24.56 1.48 25.00 
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Table 4.3: Ranking of most stable reference genes based on BestKeeper. 
Gene n 
GM 
[CP] 
AR 
[CP] 
min 
[CP] 
max 
[CP] 
SD 
[±CP] 
CV 
[%CP] 
[r] P value 
Ranking based on 
SD [r] 
ARP6 56 24.757 24.774 23.274 26.762 0.793 3.199 0.968 0.001 18s rRNA Y45F10D.4 
18s rRNA 56 14.133 14.141 13.015 15.129 0.397 2.810 0.857 0.001 U6 F35G12.2 
CDC42 56 22.999 23.019 21.163 24.883 0.833 3.619 0.978 0.001 EIF3.C TBA1 
CSQ1 56 22.560 22.595 20.165 24.880 1.109 4.907 0.971 0.001 TBA1 CDC42 
EIF3.C 56 21.632 21.648 20.135 23.661 0.687 3.172 0.968 0.001 ARP6 CSQ1 
F35G12.2 56 22.373 22.400 20.478 24.173 0.971 4.336 0.986 0.001 CDC42 ARP6 
MDH2 56 21.496 21.518 19.560 23.585 0.838 3.893 0.966 0.001 MDH2 EIF3.C 
TBA1 56 20.688 20.705 19.172 22.444 0.705 3.404 0.980 0.001 Y45F10D.4 MDH2 
U6 56 20.731 20.740 19.168 21.887 0.490 2.362 0.799 0.001 F35G12.2 18s rRNA 
Y45F10D.4 56 23.022 23.046 21.124 25.067 0.929 4.031 0.989 0.001 CSQ1 U6 
 104 
 
Table 4.4: A summary of the pair-wise mean and SD calculations for each of the reference gene candidates. The last column on the left is the average SD for 
each candidate. The latter was used in the Delta-Ct-based method to identify  the most stable genes. 
Gene  Pair 
1 
Pair 
2 
Pair 
3 
Pair 
4 
Pair 
5 
Pair 
6 
Pair 
7 
Pair 
8 
Pair 
9 
Pair 
10 
Pair 
11 
Pair 
12 
Pair 
13 
Pair 
14 
Pair 
15 
Avg. 
SD 
TBA1 Mean -2.31 -0.81 -2.12 -1.33 -0.94 -1.70 -4.07 -3.05 0.23 -0.04 -1.89 -1.39 -2.34 6.56 -3.85  
 SD 0.32 0.37 1.10 1.05 0.27 0.38 0.36 0.67 0.56 0.53 0.54 1.03 0.34 0.48 0.93 0.59 
CDC42 Mean 1.50 0.19 0.98 1.37 0.62 -1.76 -0.74 2.55 2.28 0.42 0.93 -0.03 8.88 2.31 -1.54  
 SD 0.34 1.17 1.09 0.29 0.35 0.20 0.65 0.58 0.68 0.42 1.22 0.20 0.66 0.32 0.91 0.61 
EIF3.C Mean -1.37 0.13 -1.18 -0.39 -0.75 -3.13 -2.11 1.17 0.91 -0.95 -0.44 -1.40 7.51 0.94 -2.91  
 SD 0.29 0.29 1.07 1.01 0.46 0.29 0.65 0.71 0.56 0.60 1.04 0.37 0.54 0.27 0.95 0.61 
ARP6 Mean 1.76 3.26 1.95 2.74 3.13 2.37 1.02 4.30 4.03 2.18 2.68 1.73 10.63 4.07 0.22  
 SD 0.20 0.35 1.13 1.02 0.29 0.40 0.62 0.69 0.62 0.55 1.20 0.27 0.65 0.36 0.87 0.61 
Y45F10D.
4 
Mean 0.03 1.53 0.22 1.01 1.40 0.65 -1.73 -0.71 2.57 2.31 0.45 0.96 8.91 2.34 -1.51  
 SD 0.20 0.38 1.29 1.20 0.37 0.25 0.27 0.76 0.46 0.73 0.32 1.30 0.74 0.34 0.86 0.63 
MDH2 Mean -1.50 -1.31 -0.52 -0.13 -0.88 -3.26 -2.24 1.04 0.78 -1.08 -0.57 -1.53 7.38 0.81 -3.04  
 SD 0.34 1.18 1.09 0.29 0.37 0.35 0.69 0.69 0.63 0.55 1.14 0.38 0.66 0.37 0.81 0.64 
F35G12.2 Mean -0.62 0.88 -0.43 0.36 0.75 -2.37 -1.36 1.93 1.66 -0.19 0.31 -0.65 8.26 1.70 -2.16  
 SD 0.35 0.37 1.33 1.22 0.46 0.40 0.77 0.42 0.72 0.34 1.29 0.25 0.75 0.38 0.80 0.66 
18s rRNA Mean -8.88 -7.38 -8.68 -7.89 -7.51 -8.26 -10.63 -9.61 -6.33 -6.60 -8.45 -7.95 -8.91 -6.56 -10.42  
 SD 0.66 0.66 0.89 0.88 0.54 0.75 0.65 0.64 0.90 0.46 0.92 0.71 0.74 0.48 1.13 0.73 
U6 Mean -2.28 -0.78 -2.09 -1.30 -0.91 -1.66 -4.03 -3.02 0.27 -1.86 -1.35 -2.31 6.60 0.04 -3.82  
 SD 0.68 0.63 0.83 0.82 0.56 0.72 0.62 0.63 0.96 0.97 0.76 0.73 0.46 0.53 1.11 0.73 
CSQ1 Mean -0.42 1.08 -0.23 0.56 0.95 0.19 -2.18 -1.16 2.12 1.86 0.50 -0.45 8.45 1.89 -1.96  
 SD 0.42 0.55 1.52 1.42 0.60 0.34 0.55 0.94 0.33 0.97 1.48 0.32 0.92 0.54 0.91 0.78 
RBD1 Mean 0.74 2.24 0.93 1.72 2.11 1.36 -1.02 3.28 3.02 1.16 1.67 0.71 9.61 3.05 -0.80  
 SD 0.65 0.69 1.01 0.89 0.65 0.77 0.62 1.03 0.63 0.94 1.00 0.76 0.64 0.67 1.05 0.80 
ACT2 Mean -2.55 -1.04 -2.35 -1.56 -1.17 -1.93 -4.30 -3.28 -0.27 -2.12 -1.62 -2.57 6.33 -0.23 -4.09  
 SD 0.58 0.69 1.55 1.48 0.71 0.42 0.69 1.03 0.96 0.33 1.43 0.46 0.90 0.56 0.98 0.85 
U18 Mean 1.54 3.04 1.73 2.52 2.91 2.16 -0.22 0.80 4.09 3.82 1.96 2.47 1.51 10.42 3.85  
 SD 0.91 0.81 1.65 1.51 0.95 0.80 0.87 1.05 0.98 1.11 0.91 1.50 0.86 1.13 0.93 1.06 
AMA1 Mean -0.98 0.52 -0.79 0.39 -0.36 -2.74 -1.72 1.56 1.30 -0.56 -0.06 -1.01 7.89 1.33 -2.52  
 SD 1.09 1.09 0.82 1.01 1.22 1.02 0.89 1.48 0.82 1.42 0.98 1.20 0.88 1.05 1.51 1.10 
Ce234.1 Mean -0.93 0.57 -0.73 0.06 0.44 -0.31 -2.68 -1.67 1.62 1.35 -0.50 -0.96 7.95 1.39 -2.47  
 SD 1.22 1.14 0.89 0.98 1.04 1.29 1.20 1.00 1.43 0.76 1.48 1.30 0.71 1.03 1.50 1.13 
PMP3 Mean -0.19 1.31 0.79 1.18 0.43 -1.95 -0.93 2.35 2.09 0.23 0.73 -0.22 8.68 2.12 -1.73  
 SD 1.17 1.18 0.82 1.07 1.33 1.13 1.01 1.55 0.83 1.52 0.89 1.29 0.89 1.10 1.65 1.16 
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Table 4.5: A summary for the different rankings of the 16 candidate genes derived from 5 methods in response to 
nicotine in L4 C. elegans. 
Comprehensive 
ranking 
Delta Ct 
method 
BestKeeper NormFinder GeNorm 
Gene Stabi
lity 
value 
Genes Mea
n SD 
Gene SD 
[Ct] 
Gene coeff. 
of 
corr. 
[r] 
Gene  Stabi
lity 
value 
Gene  M- 
value 
TBA1 2.51 TBA1 0.59 18s 
rRNA 
0.40 Y45F10
D.4 
0.99 TBA1 0.18 CDC42 
| 
Y45F10
D.4 
0.20 
CDC42 2.99 CDC42 0.61 U6 0.49 F35G12
.2 
0.99 EIF3.C 0.22   
EIF3.C 3.60 EIF3.C 0.61 EIF3.C 0.69 TBA1 0.98 ARP6 0.27 ARP6 0.22 
ARP6 4.24 ARP6 0.61 TBA1 0.70 CDC42 0.98 CDC42 0.29 EIF3.C 0.27 
Y45F10
D.4 
4.36 Y45F10
D.4 
0.63 ARP6 0.79 CSQ1 0.97 MDH2 0.31 TBA1 0.29 
18s 
rRNA 
5.03 MDH2 0.64 CDC42 0.83 ARP6 0.97 Y45F10
D.4 
0.38 MDH2 0.31 
U6 6.50 F35G12
.2 
0.66 MDH2 0.84 EIF3.C 0.97 F35G12
.2 
0.41 F35G12
.2 
0.33 
MDH2 6.67 18s 
rRNA 
0.73 Y45F10
D.4 
0.93 MDH2 0.97 18s 
rRNA 
0.42 CSQ1 0.36 
F35G12
.2 
8.17 U6 0.73 F35G12
.2 
0.97 18s 
rRNA 
0.86 U6 0.42 ACT2 0.41 
RBD1 9.43 CSQ1 0.78 CSQ1 1.11 U6 0.80 RBD1 0.53 18s 
rRNA 
0.47 
Ce234.
1 
10.03 RBD1 0.80 
    
CSQ1 0.64 U6 0.51 
CSQ1 10.72 ACT2 0.85     ACT2 0.71 RBD1 0.54 
AMA1 10.82 U18 1.06     U18 0.93 U18 0.60 
PMP3 11.31 AMA1 1.10     AMA1 0.95 AMA1 0.68 
ACT2 11.61 Ce234.
1 
1.13 
    
Ce234.
1 
1.00 Ce234.1 0.74 
U18 13.69 PMP3 1.16     PMP3 1.04 PMP3 0.79 
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Figure 4.1: The average Ct values calculated from raw qRT-PCR output for the 16 candidate genes in L4 C. elegans 
(N2). 50% of the values are included in the box. The median is represented by the line in the box. The interquartile 
range is bordered by the upper and lower edges, which indicate the 75th and 25th percentiles, respectively. The 
whiskers are inclusive of the maximal and minimal values, but exclusive of the outliers, represented as circles. 
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Figure 4.2: Top: geNorm ranking of the most stable gene candidates among all treatment groups and generations. 
Bottom: GeNorm-based pair-wise variation value (V value) among the candidate genes. The cut-off value being 
0.15. All values were below cutoff. Hence, the combination of two reference genes is enough to be used for 
normalization of qRT-PCR expression levels
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Figure 4.3: A box-plot graph representing the values of pairwise comparisons of the 16 genes based on dCt method. Expression levels were calculated from each 
“pair of genes” in each group. 50% of the values are included in the box. The median is represented by the line in the box. The interquartile range is bordered by 
the upper and lower edges, which indicate the 75
th
 and 25
th
 percentiles, respectively. The whiskers are inclusive of the maximal and minimal values, but 
exclusive of the outliers, represented as circles and asterisks. Different “gene pairs” are shown as different colors. The y-axis represents the ∆Ct values between 
each gene pair/group, while the x-axis shows the 16 reference candidates.
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